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ABSTRACT

Ethanol and ionizing radiation exposure are independently known to cause tissue
damage through various mechanisms. Non-enzymatic and enzymatic metabolism of
ethanol, the latter via the cytochrome P450 2E1-dependent pathway, produces free radicals
which deplete cellular glutathione (GSH). Ionizing radiation exposure has been shown to
induce lipid peroxidation, DNA damage, protein oxidation, and GSH depletion, as well.
It was postulated that initial exposure to ethanol, followed by ionizing radiation, would
result in heightened oxidative stress. The in vitro model used in this investigation was
HepG2 cells (human hepatocellular liver carcinoma cell line), while the in vivo model
was CD-1 mice. The antioxidant status of the models was evaluated by an array of
techniques. Levels of reduced glutathione, oxidized glutathione (GSSG), cysteine (CYS),
and malondialdehyde (MDA) were measured by the HPLC method. Activities of
antioxidant enzymes, catalase, and glutathione reductase (GR) were determined
enzymatically. Apoptosis was evaluated by the caspase 3 assay and fluorescence
microscopy. Our data showed that, in both of the models, combined treatment resulted in
the lowest levels of GSH, and the highest MDA and GSSG levels compared with the
control and single agent exposure. The catalase activity was significantly lower in the
combined exposure groups, when compared to the single agent exposure groups, and the
glutathione reductase activity was highest in the combined exposure groups and lowest in
the control. These findings suggest that a combination of ethanol and ionizing radiation
produces deleterious effects in vitro and in vivo through augmented oxidative stress.
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1. INTRODUCTION

Ethanol and ionizing radiation exposure are known to independently cause tissue
damage through various mechanisms. Non-enzymatic and enzymatic metabolism of
ethanol, the latter via the cytochrome P450 2E1-dependent pathway, produces free radicals
which deplete cellular glutathione (GSH). Acetaldehyde, an ethanol metabolite, has been
documented to form adducts with proteins, that can induce an immune response in the
liver, resulting in liver diseases such as hepatitis and cirrhosis. The metabolism of ethanol
by the enzymes alcohol dehydrogenase and acetaldehyde dehydrogenase produce NADH,
increasing the NADH/NAD+ ratio. High NADH/NAD+ hinders the oxidation of fatty
acids, leading to fat accumulation in the liver, resulting in fatty liver disease. Ionizing
radiation exposure has been shown to induce lipid peroxidation, DNA damage, protein
oxidation, and GSH depletion. The damaging effects of ionizing radiation are mainly due
to secondary radicals formed from radiolysis of water molecules in the cells. In spite of
the dangers posed by ethanol and ionizing radiation exposure, the number of people
exposed to these agents has continued to be on the rise as a result of increased use of
radiation therapy in cancer treatment. Unfortunately, the habit of chronic alcohol
consumption normally precedes tumor diagnosis in many individuals, and since ethanol
consumption can be addictive, breaking the habit becomes extremely difficult, even when
the health risks involved are obvious. Combined exposure studies would generate data
that can elucidate on the dangers associated with heavy ethanol consumption, and educate
the public before the consequences of their actions become irreversible.

2
1.1. REVIEW OF LITERATUTE
1.1.1 Ethanol Consumption and Metabolism. Consumption of alcoholic
beverages, containing varying percentages of ethanol, is widespread in every human
society across the globe. In almost every human culture, social events, such as
celebrations (St Pat’s Day, Independence Day), anniversaries, and parties are always
punctuated with servings of alcoholic beverages as a part of the menu. Consumption of
ethanol is documented as early as 8000 B.C [1]. In industrialized countries, alcoholic
beverages are a part of the daily meals, while in developing countries, alcohol drinking is
more often for pleasure and relaxation. The ethanol content of different beers, distilled
spirits and wines varies a great deal. Low to moderate drinking of alcohol has been
reported to have some inherent advantages such as cardioprotection, especially against
coronary heart disease and ischemia-reperfusion injury [2], and provision of calories [3].
However, alcohol drinking can lead to alcoholism; a condition characterized by craving
for alcohol and continued drinking in spite of alcohol-related problems, preoccupation
with drug alcohol, and distortion in thinking, especially denial. In this condition, the
alcohol addicts chronically take large amounts of alcoholic drinks and this leads to a
number of medical conditions that are discussed later in the text.
There are great economic losses in terms of health care, reduced or lost
productivity, destruction of property through accidents, and an increased crime rate
which can be directly attributed to alcohol drinking. Between the years of 1985 and 1990,
the economic cost of alcohol-related problems rose by 40% to $98.6 billion [4]. It has
been estimated that 100,000 people die annually in the United States from drinking and
related causes, making it the third leading cause of preventable mortality in the United
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States [5]. Enzymatic pathways of ethanol metabolism produce two byproducts, namely
acetaldehyde and NADH, which have adverse effects on the liver [6]. High
concentrations of NADH in the liver inhibit the oxidation of fatty acids leading to their
accumulation in the liver tissues. This results in a condition known as “fatty liver”.
Acetaldehyde is known to react with many functional groups in proteins, thus impairing
their function and leading to tissue damage [7]. Free radicals are also produced during
both enzymatic and non-enzymatic ethanol metabolism, causing oxidative stress [6].
Ethanol is highly soluble in water due to the hydrogen bonds it forms with water
molecules. When ethanol is consumed, it easily crosses the cell membrane, enters the
circulatory system, and is transported to various tissues and organs of the body such as
the liver, the kidney and the brain. Ethanol crosses the blood brain barrier causing lipid
peroxidation in the brain tissues [8]. This is because the brain is rich in polyunsaturated
fatty acid side chains and is low in antioxidants [9]. The enzymatic pathway of ethanol
metabolism through cytochrome P 4502E1 generates acetaldehyde and acetate and, in the
process oxidizes, NADPH to NADP+. Because this pathway uses oxygen, it generates
free radicals which cause tissue damage in the liver, leading to alcoholic hepatitis and
cirrhosis [10]. This pathway also consumes NADPH which is used to reduce GSSG to
GSH. This leads to a drop in GSH level, resulting in oxidative stress [11]. Catalase and
alcohol dehydrogenase pathways of ethanol metabolism produce acetaldehyde.
Acetaldehyde reacts with the protein’s various functional groups impairing their
functions. The primary targets include erythrocyte membrane proteins, hemoglobin,
albumin, tubulin, lipoproteins, and collagens [12].
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Accumulation of NADH from ethanol metabolism inhibits the oxidation of fatty
acids leading to a condition known as fatty liver. The free radicals produced during
ethanol metabolism include: hydroxyethyl radical, super oxide radical, peroxy radical,
and a host of other radicals.
Ethanol is metabolized through enzymatic and non-enzymatic free radical
pathways. The enzyme alcohol dehydrogenase catalyzes the oxidation of ethanol to
acetaldehyde. This reaction takes place in the cytoplasm of the liver cells in the presence
of NAD+. NADH is produced in the process. Acetaldehyde defuses into the mitochondria
where aldehyde dehydrogenase enzyme catalyzes its metabolism to ethanoic acid and
more NADH is produced [13]. Accumulation of NADH in the liver has been proved to be
responsible for the fatty liver disease. Other enzymes involved in ethanol metabolism
include catalase and cytochrome P-4502E1.
The first step of ethanol metabolism through enzymatic pathways involves
oxidation of ethanol to acetaldehyde.
Alcohol Dehydrogenase:
CH3CH2OH + NAD+

Alcoholdehydrogenase

CH3CHO + NADH + H+

Aldehyde Dehydrogenase:
CH3CHO + NAD+ +H2O

Aldehydedehydrogenase

CH3COO- + NADH + H+

Catalase:
CH3CH2OH + H2O2

Catalase

CH3CHO + 2H2O

Cytochrome P-4502E1:
CH3CH2OH + NADPH + H+ + O2

CYP2E1

CH3CHO + 2H2O + NADP+
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Non-enzymatic free radical pathway of ethanol metabolism takes place when a
hydroxyl radical abstracts a hydrogen atom from ethanol producing α- hydroxyethyl
radical as follows:
CH3CH2OH + •OH

CH3C•HOH + H2O

Hypervalent iron complexes may also catalyze this reaction without apparent
involvement of hydroxyl radical [14, 15].
The hydroxyethyl radical produced reacts with oxygen to form a peroxy radical
intermediate, which rearranges to release acetaldehyde and a super oxide radical as
follows:
CH3C•HOH +O2

CH3C (OO•) HOH

CH3C (OO•) HOH

CH3CHO + O2• - + H+

1.1.2. The Mechanism of Ethanol-Induced Oxidative Stress. The mechanism
by which ethanol induces oxidative stress has been the subject of investigation by many
leading scientists. Several mechanisms have been suggested to play an important role in
how ethanol induces oxidative stress. Some of the suggested mechanisms include: redox
state change (decrease in the NAD+/NADH ratio) as a result of metabolism of ethanol by
alcohol dehydrogenase and aldehyde dehydrogenase; acetaldehyde, mitochondrial
damage leading to less ATP production; Kupffer cell activation by endotoxin; membrane
effects; induction of CYP2E1 by ethanol; ethanol mobilization of iron resulting in
enhanced levels of low molecular weight non-heme iron; effect on antioxidant enzymes
(particularly cytosolic and mitochondrial glutathione levels); one-electron oxidation of
ethanol to 1-hydroxyethyl radical; and conversion of xanthine dehydrogenase to the
xanthine oxidase form. These pathways are interrelated and contribute to ethanol-induced
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oxidative stress. The CYP2E1 pathway of ethanol- induced oxidative stress has the
consensus of many investigators as the major pathway by which ethanol induces
oxidative stress.
At high concentrations of ethanol and chronic ethanol consumption, alcohol
dehydrogenase alone is not sufficient to metabolize all the ethanol. Under these
circumstances, CYP2E1 becomes involved in ethanol oxidation [16]. CYP2E1 is mainly
present in the liver; however, small quantities are present in other tissues such as the
brain, kidney, and gastro-intestinal tract [17]. It has the ability to oxidize ethanol to
generate reactive oxidation products such as acetaldehyde and the 1-hydroxyethyl radical.
Additionally, it can activate various agents such as carbon tetrachloride, acetaminophen,
benzene, halothane, halogenated alkanes, and alcohol to reactive products and generate
reactive oxygen species. Ethanol increases levels of CYP2E1 by a posttranscriptional
mechanism that leads to its stabilization against degradation. The catalytic cycle of
CYP2E1, a loosely coupled enzyme, generates reactive oxygen species such as super
oxide radical and hydrogen peroxide. The iron level is normally increased after ethanol
treatment and enhances the production of more powerful oxidants such as hydroxyl
radical, ferryl species, and 1-hydroxyethyl radical. Toxicity of these reactive oxygen
species is due to protein oxidation and enzyme inactivation and damage to the cell
membrane through lipid peroxidation, and production of reactive lipid aldehydes such as
malondialdehyde and 4-hydroxynonenal. Damage to mitochondrial membrane by the
ROS leads to a decrease in the membrane potential and alters the membrane permeability.
This causes apoptosis to occur due to the release of proapoptotic factors.
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1.1.3. Evidence from Previous Research. There is strong evidence from research
suggesting that ethanol induces developmental toxicity in organisms. Investigation
conducted by Reimers et al. [18], using zebrafish exposed to ethanol and acetaldehyde
established a number of developmental malfunctions such as pericardial edema, yolk sac
edema, axial malformations,

delayed development and axial blistering. Reduced

exposure to ethanol and acetaldehyde led to a proportional decrease in the effects.
Studies conducted by Gohlke et al. [19] using rat models, investigated ethanolinduced neocortical neuronal cell death during the synaptogenesis period. This study
suggested that ethanol induces inhibition of proliferation during neurogenesis, and
apoptosis. Sakuta et al. [20] have studied the relationship between heavy alcohol intake
and homocysteine levels in type 2 diabetes. They found elevated levels of homocysteine
in heavy alcohol drinking diabetic patients. Homocysteine is pro-oxidant [21], oxidizing
low-density lipoproteins, thus enhancing the atherosclerosis process.
Ethanol consumption has been implicated in deaths due to acute ethanol
poisoning [22]. Jones et al. conducted a study in which they compared the blood-ethanol
concentration in deaths attributed to acute alcohol poisoning and chronic alcoholism.
Alcoholic ketoacidosis was suggested as a more probable cause of death since more death
cases had very high concentrations of acetone in the blood.
Research conducted by Agnieszka et al. [23] relates alcoholic liver cirrhosis and
apoptosis of blood mononuclear cells. The result of their study showed that peripheral
blood mononuclear cells (PBMCs), isolated from the blood of patients with alcoholic
cirrhosis, showed accelerated spontaneous apoptosis after a 24-hr incubation period in in
vitro compared to the PBMCs from the blood of healthy patient.
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Besides the production of free radicals and the reactive oxygen species from
ethanol metabolism, ethanol has been shown to increase the levels of bacterial protein
called endotoxin in the blood and the liver [24]. The presence of endotoxin in the blood
and the liver activates the immune cells called Kupffer cells in the liver to produce TNFα, which in turn, activate another type of cells (stellate cells) in the liver to produce
transforming growth factor beta (TGF-β), and collagen, which promotes scar tissue
formation (fibrosis). The release of other types of cytokines such as interleukin-8 (IL-8)
is also induced by TNF-α. This leads to the attraction of the inflammatory cells from the
blood stream to the liver, causing inflammation of the liver. The acetaldehyde produced
during enzymatic metabolism of ethanol, forms adduct with proteins, lipids, and the DNA
molecules. The presence of these adducts in the blood stream also lead to the activation
of certain immune cells such as IL-1, IL-2 and TNF-α. The activation of these immune
cells leads to the attraction of inflammatory cells to the liver, resulting in inflammation,
fibrosis, and organ damage. A summary of all the pathways by which ethanol metabolism
induces the production of reactive oxygen species, and activates the diverse pathways
which lead to apoptosis and organ damage is illustrated in Figure 1.1. It is apparent that
there are numerous pathways by which ethanol can cause tissue damage and the onset of
disease. There seems to be endless pathological conditions that ethanol consumption can
initiate. The on going research on ethanol and its effects on the biological systems has
uncovered very essential mechanisms by which ethanol induces damage to tissues, and
created un awareness on potential dangers that heavy alcohol drinking can potentiate.
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Figure 1.1. Pathways through which ethanol induces apoptosis and tissue damage [24].

1.1.4. Ionizing Radiation. Ionizing radiation is high-energy radiation capable of
producing ionization on the atoms of the molecules it comes into contact with. The atom
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becomes ionized when the radiation energy it absorbs is equal to or greater than the
ionization energy of that atom, which results in an electron being ejected from the atom
(illustrated in Figure 1.2). Alternatively, the energy absorbed may not be sufficient to
eject an electron from an atom, resulting in excitation of an electron(s) (illustrated in
Figure 1.3). Ionizing radiation is characterized by localized release of large amounts of
energy [25].

Figure 1.2. Ionization of an atom by ionizing radiation.
(www.fas.org/.../usa/doctrine/dod/fm8-9/1ch2.htm)

The radiations capable of producing such an effect on the atoms of the target
molecules in the biological systems are called ionizing radiation. The particulate
radiations (have high linear energy transfer) that travel short distances and release all of
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their energies on their paths are the most ionizing. Alpha particles and neutrons are
examples of highly ionizing radiations.

Figure 1.3. Excitation of an atom by ionizing radiation.
(www.fas.org/.../usa/doctrine/dod/fm8-9/1ch2.htm)

This type of effect is caused by low linear energy transfer radiations such as Xrays and γ-rays. The excited molecules produce secondary radicals, which in turn cause
damage to the biological targets.
1.1.5. Types of Ionizing Radiation. Ionizing radiation is classified as
electromagnetic radiation, such as X-rays and γ-rays, and particulate radiations has forms
such as α-particle and β-particles, neutrons and protons. X-rays are electromagnetic
radiation of short wavelengths produced when high-speed electrons strike a solid target,
while γ-rays are electromagnetic radiation produced by decomposition of unstable
radionuclide. X-rays and γ-rays are low linear energy transfer radiation and produce most
of their effects in the biological systems by indirect action, while particulate radiations
(α-particles, neutrons, protons) are high linear energy transfer radiations and produce
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their effects by direct action. Linear energy transfer (LET) is the number of ionizations
which radiation causes per unit distance as it passes through the cells. The damaging
effects of ionizing radiation are consequences of both direct and indirect actions. It has
been estimated that 60%-70% of radiation-induced tissue damage is due to free radicals,
particularly the hydroxyl radical (•OH) [26]. The DNA molecule is the most critical target
of ionizing radiation, and suffers extensive oxidative damage by both direct and indirect
mechanisms of exposure [27]. A segment of the DNA molecule is shown in Figure 1.4.

Figure 1.4. A segment of the DNA molecule.
(http://web.umr.edu/~nercal/chem 361 lecture)
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The DNA suffers single and double strand breaks, and base modifications due to
direct and indirect actions of radiation. Radiolysis of water produces •OH, which has been
shown to produce the most damage to the DNA molecules [28].
1.1.6. Direct Action of Radiation. The direct action of radiation on biological
systems is caused mostly by particulate radiation when the particles have sufficient
kinetic energy to disrupt the atomic structure of the atoms of the absorbing molecule,
resulting in chemical and biological changes. The alpha particles and neutrons are high
LET radiations and produce their effects on biological systems by direct action.
1.1.7. Indirect Action of Radiation. The indirect action of radiation is caused by
electromagnetic radiations: X-rays and γ-rays, which do not produce biological changes
themselves, but induce the production of free radicals, which mediate the radiation
damage. When these radiations are absorbed by cells, the water in the cells becomes
charged due to loss of the electron.
H2O → H2O+ + eThe water molecule loses an electron as a result of the interaction with
electromagnetic radiation to form a water radical cation, which is a strong acid. The water
radical cation donates a proton to water, forming the hydronium ion and the hydroxyl
radical.
H2O+ + H2O →H3O+ + •OH
The hydroxyl radicals formed can react with biological targets such as DNA,
proteins, lipids, and other molecules and structures in the cells, or recombine to form
hydrogen peroxide
•

OH + •OH → H2O2
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The energy absorbed may, alternatively, cause radiolysis of water molecules to
form the hydrogen and hydroxyl radicals.
H-O-H

radiolysis

•

OH + H•

The •OH radical formed by radiolysis of water molecules has been reported to
damage 60%-70% of the DNA molecules. The interaction of free radicals with DNA
bases and sugars produces the most significant damage to DNA, which includes: oxidized
bases, DNA-DNA strand adducts, DNA single and double strand breaks, DNA-protein
cross-links, and various forms of aberrations [29]. Guanine is the DNA base that is most
susceptible to attack by free radical, forming 8-hydroxyguanine [30-31]. The attack on
the sugar moieties leads to cleavage of the sugar-phosphate backbone of DNA resulting
in strand breaks. The free radicals also attack proteins and lipids, resulting in protein
oxidation and lipid peroxidation [32].

1.2. EFFECTS OF FREE RADICALS ON BIOLOGICAL SYSTEMS
The free radicals produced by ethanol and ionizing radiation produce major
biological changes, which can be classified as DNA damage, lipid peroxidation, and
protein oxidation [33].
1.2.1. DNA Damage. The DNA molecule has many specific sites that are prone
to attack (hot spots) by the ROS, as shown in Figure 1.5. The attacks can occur on the
DNA bases or the sugar-phosphate backbone, resulting in DNA double and single strand
breaks, and numerous base and sugar modifications.
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Figure 1.5. Hot spots for free radical attack on the DNA molecule.
(Freya Q. Schafer, PhD. Oxidative DNA damage. Sunrise Free Radical school, 1997)

The attack on the DNA molecule by the •OH radical can fall in to three categories,
namely, hydrogen abstraction, addition, and electron transfer [34]. These reactions have
the potential of causing damage to all of the four bases and the deoxyribose sugar.
The •OH radical reacts with the bases in the DNA molecule by addition. In
pyrimidines, such as thymine, the •OH radical adds to the C5-C6 double bond, forming
base radicals, of which 5-hydroxy-6-yl radicals have reducing properties, while the 6-
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hydroxy-5-yl radicals are oxidizing [35]. The free radical can also abstract a hydrogen
from the methyl group of thymine, resulting in radical formation. The reactions of the
•

OH radicals with the pyrimidines are shown in Figure 1.6.
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Figure 1.6. Hydroxyl radical attack on thymine.
(Adapted from: von Sontag C. (1987). The chemical basis of radiation biology, Taylo &
Francis London, NY)

The •OH radical reacts with purines by adding to C4, C5, and C8 positions
resulting in equal amounts of oxidizing and reducing adduct radicals [36]. The C4-OH
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and C5-OH radicals dehydrate and are converted to oxidizing radicals [37]. These
reactions are shown in Figure 1.7
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Figure 1.7. Hydroxyl radical attack on guanine (purine).
(Adapted from: von Sontag C. (1987). The chemical basis of radiation biology, Taylo &
Francis London, NY)

A wide range of oxidized DNA base products are shown in Figure 1.8. These
modifications have been suspected to be responsible for various types of mutations and
tumor development, and many disease conditions.
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Figure 1.8. Base products of oxidative damage to DNA [38].
(Adapted from Dizdaroglu M. (1992). Free. Radic. Biol. Med.)

Attack by the •OH radical on the deoxyribose sugar leads to an abstraction of
hydrogen (possible in all the five carbons of the ribose sugar), and subsequent formation
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of carbon-centered radicals. The carbon centered radicals can react with oxygen to form
peroxyl radicals. Additionally, the radicals can react with each other forming non-radicals
[39]. The C4’ –centered radical can undergo β cleavage under anaerobic conditions,
resulting in DNA strand breakages and the release of an intact base and altered sugars
[40]. The sugar lactone, and an intact base are formed when the C1’-centered radical is
oxidized [41]. The oxidation of sugar phosphate backbone is shown in Figures 1.9 and
1.10.

Figure 1.9. Attack of free radicals on the sugar phosphate backbone.
(Adapted from: von Sontag C. (1987). The chemical basis of radiation biology, Taylo &
Francis London, NY)

These types of attacks result in single and double strand DNA breakages. The
single strand breaks are normally easily repaired by the DNA repair enzymes. However,
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the double strand breakages are very difficult to repair, and usually result in apoptosis,
mutagenesis, and carcinogenesis [42].
The oxidation of sugar phosphate backbone is shown in Figures 1.9 and 1.10.

Figure 1.10. Attack on the deoxyribose.
(Adapted from: von Sontag C. (1987). The chemical basis of radiation biology, Taylo &
Francis London, NY)

The modified bases can react with proteins, forming DNA-protein cross-links,
shown in Figure 1.11 [43]. These in turn can trigger other signal transduction pathways.
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1.2.2. Lipid Peroxidation. Lipid peroxidation is a biological free radical chain
reaction that is responsible for the formation of a wide range of products, in including
aldehydes, ketones, and cyclic peroxide radicals in the cells [44]. The mechanism of lipid
peroxidation is shown in Figure 1.12.
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Figure 1.12. Lipid peroxidation mechanism (polyunsaturated fatty acids).
(Bucher JR, Tien M. et al., (1983). Biochem. Biophys. Res. Commun. 111: 777-784)

The lipid peroxidation chain reaction is initiated by an abstraction of a hydrogen
atom from a methylene carbon in a polyunsaturated fatty acid (such as arachidonic acid)
by a hydroxyl radical, forming lipid radicals. The presence of many carbon-carbon
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double bonds makes the abstraction of hydrogen easier. The carbon-centered lipid
radicals formed rearrange and react with molecular oxygen in an aerobic environment to
form peroxyl radicals. The peroxyl radicals formed abstract hydrogen from the side
chains of neighboring polyunsaturated fatty acids (PUFA) and combine with the
abstracted hydrogen to form hydroperoxides, and propagate the chain reaction; combine
with each other, and attack membrane proteins [45]. The lipid hydroperoxides decompose
in the presence of metals, such as iron or copper to form products, which include ethane
and pentane gas, unsaturated aldehydes such as 4-hydroxy-2-nonenal (4-HNE), and
malondialdehyde (MDA) [46-48]. Lipid peroxidation has been implicated in the
pathological conditions associated with atherosclerosis, ischemic or traumatic brain
damage [44].
1.2.3. Protein Oxidation. Protein oxidation is the covalent modification of a
protein induced either directly by reactive oxygen species or indirectly by reaction with
secondary by-products of oxidative stress [49]. The damage caused on proteins due to
oxidation can result in functional changes, which includes inhibition of enzymatic and
binding activities; increased susceptibility to aggregation and proteolysis; decreased
uptake by cells; altered immunogenisity; induction of apoptosis, and necrosis, altered
gene regulation and expression, and modulation of cell signaling [50]. The oxidative
changes can lead to backbone fragmentation, aliphatic-side chain oxidation, and aromatic
side-chain oxidation. The ROS can abstract hydrogen from an α-carbon in an aliphatic
residue as shown in Figure 1.13.
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The abstraction of hydrogen at an alpha-carbon can result in backbone
fragmentation. Side chain oxidation on aliphatic residue can occur at a tertiary carbon or
primary carbon, resulting in altered protein structure, shown in Figure 1.14.
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Backbone fragmentation on a protein can occur when a hydrogen is abstracted
from an alpha carbon, followed by addition of oxygen to form peroxyl radicals. The
peroxyl radicals can undergo hydrolys, which results in fragmentation. Alternatively, the
peroxyl radicals can abstract hydrogen from the neighboring molecules to form
hydroperoxides, which eventually fragment to form products shown in Figure 1.15.
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The aromatic side chain oxidation occur by addition of hydroxyl radical on to the
aromatic ring, leading to transformations from phenyalanine to ortho and meta-tyrosine
product, and from tyrosine to 2,3-dihydroxyphenyalanine (DOPA) [53]. The
transformations are shown in Figure 1.16. Protein oxidation products have been used as
biomarkers of oxidative stress.
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Figure 1.16. Specific aromatic side chain oxidation products [51].
(Davis MJ. Protein oxidation: concepts, mechanisms and new insights. Sunrise Free
Radical School)

1.3. THE ANTIOXIDANT DEFENSE SYSTEM
Aerobic organisms have developed an elaborate system of antioxidant molecules
and enzymes to counter the damaging effects of free radicals and reactive oxygen species
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[54]. GSH is the most abundant antioxidant in the body, and is found in all mammalian
cells. It is a tripeptide made of the amino acids: glutamate, cysteine, and glycine, as
shown in Figure 1.17. The SH functional group in cysteine makes glutathione a potent
antioxidant and the first line of defense against free radicals and xenobiotics. The
antioxidant enzyme system is made of the enzymes: glutathione peroxidase, which
decomposes organic and inorganic peroxides; glutathione reductase, which reduces
oxidized glutathione to regenerate reduced glutathione; catalase, which decomposes
hydrogen peroxide to water and oxygen; superoxide dismutase, which dismutates the
superoxide radical [55-57]; and many others.

Figure 1.17. Glutathione, the principal antioxidant in mammalian cells.
(web.indstate.edu/.../aminoacidderivatives.html)
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Glutathione counters the oxidative stress by the following mechanisms:
Free radical scavenging,
GSH + OH• → GS• + H2O
Hydrogen donation.
R• + GSH → RH + GS•
Restore oxidized DNA
GSH + DNA• → DNA + GS•
Regenerate other antioxidants
Vit C• + GSH → Vit C + GS•
Reduce lipid peroxides
2GSH + ROOH

GPx

2H2O + ROH + GSSG

1.4. SIGNIFICANCE OF COMBINED EXPOSURE STUDIES
Studies have shown that, at high levels of exposure, chemical and physical agents
may have additive/synergistic effects in the biological systems. Additionally,
investigators have performed single agent exposure studies, while assuming that the agent
under study would act independently of other preexisting conditions or agents [58].
Furthermore, the end points that have been measured by investigators in previous
combined-exposure studies have been clinical outcomes, such as tumor induction,
radiosensitization, or radioprotection, and not antioxidant status [59-61]. This
investigation is the first complete combined-exposure investigation, using model in vitro
and in vivo systems to determine the effects of a combination of ethanol and ionizing
radiation on the antioxidant status of the systems. This study has the potential for
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generating vital data that could be used to advise prospective radiation therapy patients.
Additionally, this research offers a legitimate premise for advising the general public
about the dangers of indulging in habits such as binge drinking and excessive use of
alcohol. The on going research is bound to shed more light on effects of ethanol and
radiation, and their interactions with biological systems. The onset of cancer generally
occurs, in a majority of cases, from middle to old age, when habits such as cigarette
smoking, alcoholism, and other habits are well established, and breaking such habits due
to medical reasons always does not succeed. The data from this research can be used to
offer advice against such harmful habits when there are still chances of recovery.
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2. EFFECTS OF COMBINED EXPOSURE TO ETHANOL AND IONIZING
RADIATION ON THE ANTIOXIDANT STATUS OF AN IN VITRO MODEL

2.1. INTRODUCTION
The combination of ionizing radiation and ethanol exposure can potentially be
extremely toxic to tissues due to heightened oxidative stress. Ethanol and/or radiation
exposure induce the production of reactive oxygen species (ROS) [62-66].
The enzymatic pathway of ethanol metabolism through cytochrome P4502E1
(CYP 2E1) generates directly, besides acetaldehyde and acetate, ROS [67-68]. The latter
can trigger protein oxidation, enzyme inactivation, DNA damage, damage to the cell
membrane through lipid peroxidation, and production of reactive lipid aldehydes such as
MDA and 4-hydroxynonenal (4HNE). This pathway also consumes NADPH, which is
used to reduce GSSG to GSH, leading to a drop in the GSH levels of cells. Moreover,
ROS are formed during the non-enzymatic oxidation of ethanol. Numerous studies have
shown that ionizing radiation also generates ROS in biological systems, resulting in
oxidative damage to macromolecules such as DNA, lipids and proteins [69-71].
Ionizing radiation can interact directly with critical targets in the cells, such as
DNA by energy transfer, causing ionization of the atoms, and subsequent biological
changes. Additionally, the radiation may also interact with water molecules to produce
free radicals indirectly in a series of reactions: H2O → H2O+ + e-; H2O+ + H2O →H3O+ +
•

OH ;•OH + •OH→H2O2
These free radicals can then interact with macromolecules, such as DNA, to cause

biological changes (indirect action).
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Chemotherapeutic and radiotherapeutic treatment modalities have relied on the
oxidative damage by free radicals to eradicate tumors [72] and in the process, unintended
damage to normal tissues often occurs. Since ethanol and ionizing radiation can both
increase free radical levels significantly, the need to better understand the interplay of
exposure to ethanol prior to ionizing radiation (XRT) becomes necessary. Assessment of
risks in having some other agent or condition present prior to or coincident with radiation
exposure, has usually relied on the implicit assumption that radiation would act
independently of other pre-disposing conditions or substances already present in the
system at the time of exposure. Recent studies of interactions, however, have shown that
at high exposures, the action of one agent or condition can be influenced by simultaneous
exposure to other agents or conditions [73]. There are numerous reports of investigations
conducted to determine the effect of combined exposure of radiation with other physical
and chemical agents, namely, tobacco, bleomycin, 5-fluorouracil, glutamine, N-acetyl
cysteine, paraquat (superoxide generating agent), cyclophosphamide, and many others.
The end points measured have been various including combined action against cancers,
radiation protection of normal tissues, and tumor induction [74-75]. Other medical
conditions, such as diabetes, hypertension, or collagen vascular diseases, may also affect
the risks of complications attributed to XRT. Therefore, in these sets of experiments, the
effects of in vitro exposure of HepG2 cells to varying concentrations of ethanol for 24 h,
followed by radiation, and then analysis 24 h later was investigated. In order to assess the
antioxidant status, the parameters such as GSH, CYS, MDA, and activities of some
antioxidant enzymes (catalase and glutathione reductase) were measured. Cell viability

32
was measured using the MTS assay and apoptosis by caspase-3 apoptotic assay and by
fluorescence microscopy.

2.2. EXPERIMENTAL DESIGN
2.2.1. Ethanol Dose-Dependent Studies on HepG2 Cells. The ethanol dose
dependent studies were conducted in order to determine the right concentration of ethanol
to be used in the rest of the in vitro experiments. The cells were allowed a 24 h
incubation period for attachment, followed by incubation with varying concentrations of
ethanol (10-100 mM) for 48 h. At the end of the treatment period, the cells were collected
by trypsinization, homogenized and derivatized, and levels of GSH determined.
2.2.2. Radiation Dose-Dependent Studies on HepG2 Cells. These experiments
were done in order to determine the right radiation dose to be used for the rest of the
experiments. The cells were incubated for 24 h to allow attachment, followed by a change
of media and further 24 h incubation, after which the cells were exposed to varying
radiation doses (2-10 Gy). The cells were collected, homogenized, and derivatized to
determine the GSH levels 24 h after irradiation.
2.2.3. Oxidative Stress Studies. The cellular levels of oxidative stress markers
such as GSH, CYS, and MDA were measured after the cells had been exposed to ethanol,
followed by ionizing radiation. The activities of some antioxidant enzymes (GR and
CAT) were also measured. The objective of performing these experiments was to
determine the antioxidant status of the cells, in order to assess the effects of ethanol and
radiation on HepG2 cells.
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2.2.4. Cell Viability Studies. The cell viability was determined by the MTS
assay. The tetrazolium compound (MTS) was reduced to a formazan product by NADPH
produced by the dehydrogenase enzyme in the living cells. The formazan product has an
absorbance at 490 nm, which is directly proportional to the number of the living cells.
The cells were exposed to ethanol followed by radiation, then the MTS reagent was
added to the cell in a 96-well plate, and the absorbance was read after 2 h. The cell
viabilities in the various groups were determined as the percentage of the untreated
control.
2.2.5. Apoptosis Studies. The caspase-3 assay and fluorescent microscopy
procedures were used to determine the apoptotic process in the cells. The details of these
procedures are given under the materials and methods section.

2.3. MATERIALS AND METHODS
2.3.1. Materials. HPLC-grade acetonitrile, glacial acetic acid, water, and
phosphoric acid, used for the preparation of mobile phase, were purchased from Fisher
Scientific (Fair Lawn, NJ USA). N-(1-pyrenyl)-maleimide (NPM), used as a derivatizing
agent for measurement of CYS and GSH, 1,1,3,3-tetramethoxypropane, and ethanol were
purchased from Aldrich (Milwaukee, WI USA). Protein concentration was evaluated with
the Bradford reagent obtained from BioRad (Melville, NY USA). Dulbecco’s Modified
Eagle Medium (DMEM), heat inactivated fetal bovine serum, L-glutaMax, penicillin
and/streptomycin, sodium pyruvate, and non-essential amino acids were purchased from
Invitrogen Corporation (Carlsbad, CA USA). Acridine orange (AO), ethidium bromide
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(EB), and all other chemicals were purchased from Sigma (St. Louis, MO USA). 25 cm2
culture flasks and 0.2-µm filters were purchased from Advantech MFS, Inc. (Dulin, CA
USA). Human hepatocellular liver carcinoma (HepG2) cells were provided by Dr. Helen
Anni from Thomas Jefferson University in Philadelphia, PA USA. Caspase-3 activity
assay kit was purchased from R&D Systems, USA, while CAT and GR activity assay kits
were purchased from OxisResearch ™.
2.3.2. Culture of HepG2 Cells. HepG2 cells were grown in high glucose
DMEM, supplemented with 1 % of L-glutaMax, penicillin and streptomycin, sodium
pyruvate, non-essential amino acids, and 10 % heat inactivated fetal bovine serum (FBS).
The cells were seeded at a density of 1.5 million cells per ml in T-25 culture flasks with 5
ml of complete medium and cultured at 37 o C with 5 % carbon dioxide.
2.3.3. Ethanol and Radiation Treatment. After 24 h, attached cells were treated
with varying concentrations of ethanol (10-100 mM), for 24 h. Irradiation of the cells (8
Gy) was performed with a 9 MeV beam generated by a Varian Linear accelerator, model
21 EX (Varian Associates, Walnut Creek, CA, USA) using a 20 x 20 or 25 x 25 cm field
at the Radiation Oncology Department of the Phelps County Regional Medical Center in
Rolla, Missouri. The cells were further incubated for 24 h after radiation, and then
trypsinized, homogenized, and immediately analyzed, or stored at -80

o

C for later

analysis of CYS, GSH, MDA, and antioxidant enzymatic activities.
2.3.4. Thiols Determination. The derivatizing agent, N-(1-pyrenyl) maleimide,
reacts with thiols (GSH, CYS, NAC, HCYS) to form a fluorescent adduct that can be
quantified by the HPLC method, with fluorescent detection. This procedure was used to
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determine the levels of glutathione and cysteine in HepG2 cells after homogenization and
derivatization.
2.3.5. Protein and Enzyme Activity Determination. A Hitachi U-2000 double
beam UV-Vis spectrophotometer (Tokyo, Japan) was used to measure protein
concentration using the Bradford assay [76] and antioxidant enzyme activities. A Fluostar
OPTIMA microplate reader (BMG Labtechnologies. Inc, Durham, NC) was used for
MTS and caspase-3 assays.
2.3.6. Determination of GSH and CYS Levels. Cellular levels of GSH and CYS
were determined by RP-HPLC, according to the method developed in our laboratory [77].
The HPLC system (Thermo Electron Corporation) consisted of a Finnigan Spectra
System vacuum membrane degasser (model SCM1000), gradient pump (model P2000),
autosampler (model AS3000), and fluorescence detector (model FL3000) with λex =
330nm and λem = 376 nm. The HPLC column was a Reliasil ODS-1 C18 column (5 µm
packing material) with 250 x 4.6 mm (Column Engineering, Ontario, CA, USA). The
mobile phase was 70% acetonitrile and 30% water and was adjusted to a pH of 2 with
acetic acid and o-phosphoric acid. The NPM derivatives of CYS and GSH were eluted
from the column isocratically at a flow rate of 1mL/min.
2.3.7. MDA Determination. The MDA determination was done by RP-HPLC
method using λexc = 515 nm; the λem 550 nm [78]. Cell homogenate (350 μl) was mixed
with butylated hydroxytoluene (100 μl of 500 ppm), and 10% trichloroacetic acid (550
μl) and boiled for 30 min. After the solution was cooled on ice and centrifuged for 10 min
at 1500 x g, the supernatant (500 μl) was mixed with thiobarbituric acid (TBA) (500 μl).
The tubes were boiled again for 30 min, and then cooled on ice. A solution (500 μl) was

36
added to n-butanol (1.0 ml), vortexed, and centrifuged for 5 min at 60 x g to facilitate a
phase separation. The top layer was then filtered through 0.45 μm filters and injected
onto a 5 μm C18 column (250 x 4.6 mm) on a RP- HPLC system. The mobile phase
consisted of 69.4% 5mM sodium phosphate buffer pH = 7.0, 30% acetonitrile, and 0.6%
tetrahydrofuran.
2.3.8. Cell Viability Determination. This assay uses the novel tetrazolium
compound,

MTS

(3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-

sulfophenyl)-2H-tetrazolium), that is reduced by NADPH or NADH (produced by
dehydrogenase enzyme in the living cells) into formazan, which is soluble in tissue
culture medium. The Cell Titer 96® AQueous Cell Proliferation Assay (Promega
Corporation, Madison, WI, USA) was used to determine of cell viability in the various
groups. The absorbance of the formazan product was measured using 96-well microplates
at 490 nm [79-80]. The production of formazan is proportional to the number of living
cells; therefore, the intensity of the color produced is a good measure of cell viability.
100 µL cell suspension of HepG2 cells (approximately 5 x 103 cells) were seeded into
each well of the 96-well microplate and incubated for 24 h for the cells to attach. The old
media was removed and fresh medium, with different concentrations of ethanol, was
added to the ethanol groups. The control and XRT only groups received complete media
without ethanol. The cells were incubated for an additional 24 h, then the XRT and
ethanol and XRT groups were exposed to radiation, while the control group did not
receive any radiation. The cells were returned to an incubator maintained at 37 o C, 95%
air, and 5% CO2 for an additional 24 h after radiation. Then 20 µL of MTS tetrazolium
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reagent were added to each well. The absorbance at 490 nm was read after 2 h incubation
with the MTS reagent.
2.3.9. Apoptosis Measurements. The caspase-3 apoptotic assay was performed
using a colorimetric substrate, as per the manufacturer’s instructions (R&D Systems, Inc.
MN). Briefly, 25µl of lysis buffer per 1x106 cells were added to each pellet that was
collected after treatment. The cell suspension was incubated on ice for 10 min and then
centrifuged at 10,000 x g for 3 min. 50 µl of the supernatant, along with 50 µl of the 2X
reaction buffer containing 0.1 M dithiothreital (DTT) and 5 µl of the caspase-3
colorimetric substrate (DEVD-pNA) were added to each well in a 96-well plate. The
plate was then incubated for 2 h before the absorbance was read by a microplate reader at
405 nm.
Apoptosis was also evaluated by fluorescence microscopy. HepG2 cells (3.5 x
106 cells/ml), were centrifuged at 150 x g for 5 min to pellet the cells, and then washed
once with cold PBS (5 ml). The cells were resuspended in cold PBS (1 ml), and then 25
µl of the cell suspension was mixed with 2 µl of EB/AO dye mix. Stained cells (10 µl)
were placed on a clean microscope slide and covered with a cover slip and viewed using
an Olympus IX51 inverted microscope at 400X total magnification using a UPLFLN
60X NA 1.25 objective. FITC (EX 482/35 506DM EM536/40) and TexasRed (EX
562/40 593DM EM 692/40) filters were used (Brightline). Images were captured with a
Hamamatsu ORCA285 CCD camera. Shutters, filters, and camera were controlled using
SlideBook software (Intelligent Imaging Innovations, Denver, CO).
2.3.10. Catalase Activity. The activity of catalase (CAT; EC 1.11.1.6) in the cell
homogenates was measured spectrophotometrically at 240 nm following the exponential
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disappearance of hydrogen peroxide (H2O2; 10 mM) according to the method described
by Aebi [81]. The catalase activity is calculated from A60 = Ainitial e-kt where k, is the rate
constant, Ainitial , is the initial absorbance, and A60 is the absorbance at 60 s.
2.3.11. Glutathione Reductase Activity Assay. Glutathione reductase (GR; EC
1.6.4.2) activity was measured spectro-photometrically at 340 nm following the decrease
of NADPH using a commercial kit from OxisResearch™ (Portland, Oregon, U.S.A). This
reaction maintains the normal levels of cellular glutathione, essential for keeping the
levels of free radicals and organic peroxides down.
2.3.12. Statistical Analysis. The data were analyzed with Student’s t test and one
way ANOVA. Calibration curves were plotted and linear equations from the calibration
standards were used to determine the parameters to be measured. All experiments were
performed in triplicate, and the values reported are mean ± SD.

2.4. IN VITRO RESULTS
2.4.1. Ethanol Concentration Dependent Experiments. Figure 2.1 shows the
results of increasing concentrations of ethanol (10 – 100 mM) on the levels of GSH in
HepG2 cells The cells were exposed to different concentrations of ethanol for 48 h, and
then GSH was measured. This experiment was performed to determine the optimal
concentration of ethanol to be used in the combined exposure group. As can be seen from
this figure, there is a nearly linear decrease in the level of GSH with an increasing
concentration of ethanol. The GSH levels of the ethanol treated groups were significantly
lower as compared to those of the control group.
.
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Figure 2.1. Effects of ethanol (10 – 100 mM) on the levels of GSH in HepG2 cells.
The cells were incubated with ethanol for 48 h, and then GSH levels were measured by
the HPLC method after derivatization with NPM. The GSH levels decreased linearly with
increases in ethanol concentration (pro: protein).

2.4.2. Radiation Dose Dependent Experiments. Figure 2.2 shows how the levels
of GSH in HepG2 cells vary when exposed to varying radiation doses (2 – 10 Gy). There
is a nearly linear decrease in the levels of GSH that coincides with increases in radiation
doses. The GSH levels in the radiation exposed groups are significantly lower than those
of the control. This experiment was performed to determine the appropriate radiation
dose to be used in combined exposure studies.
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Figure 2.2. Effects of radiation (2 – 10 Gy) on the levels of GSH in HepG2 cells.
Confluent cells were exposed to doses of radiation ranging from 2 to 10 Gy, and then
analyzed 24 h later. The GSH levels decreased linearly with increasing doses of radiation.

2.4.3. GSH levels in Combined Exposure Experiments. Figure 2.3 shows the
GSH levels in different treatment groups. Four groups, in triplicate, were designated as:
(I) Control: no exposure to ethanol or radiation; (II) 50 mM ethanol, no radiation; (III)
radiation (8 Gy), no ethanol; (IV) ethanol (50 mM) for 24 h, followed by radiation (8
Gy). The GSH level in the control group was significantly higher than those in the single
agent and combined exposure groups. The GSH levels in the single agent (ethanol or
radiation) exposure groups were significantly higher than those in the combined exposure
group. The chromatograms in Figures 2.4 to 2.7 show changes in the areas under the
curves, indicating variations in the levels of GSH and cysteine in the four experimental
groups.
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Figure 2.3. Combined effects of ethanol and radiation on the levels of GSH.
The levels of GSH were determined in groups designated as: control, ethanol only (50
mM), radiation only (8 Gy), and ethanol (50 mM) + radiation (8Gy). The ethanol and
radiation group was exposed to ethanol (50 mM) for 24 h, followed by radiation (8 Gy),
then analysis 24 h later. * Significantly different compared to control (p < 0.05). **
Significantly different compared to combined exposure group (p < 0.05).
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Figure 2.4. Chromatogram of control HepG2 cells.
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The NPM derivatives were measured by a fluorescence detector (λex = 330 nm and λem =
376 nm). Flow rate was 1ml/min. The GSH peak at a retention time of 7.90 min was the
highest, and the CYS peak was at retention time of 10.73 min. The hydrolysis peak (due
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Figure 2.5. Chromatogram of HepG2 cells incubated with 50 mM ethanol.
The separation conditions were the same as mentioned in Figure 2.4.
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Figure 2.6. Chromatogram of HepG2 cells exposed to radiation (8 Gy).
The separation conditions were the same as mentioned in Figure 2.4.
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Figure 2.7. Chromatogram of HepG2 cells exposed to ethanol and radiation.
The separation conditions were the same as mentioned in Figure 2.4.

2.4.4. Cysteine Levels. Figure 2.8 shows changes in the cysteine levels in the
different treatment groups. The cysteine level in the control group was higher than that in
the ethanol (50 mM) only group, but significantly lower than the ethanol (50 mM) and
radiation (8 Gy) groups. The control and radiation (8 Gy) only groups had almost the
same levels of cysteine.
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Figure 2.8. Cysteine levels in the control and treatment groups. 50 mM ethanol decreased
the level of cysteine significantly compared to control, while 8 Gy radiation had the same
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level of cysteine as the control. The ethanol (50 mM) + radiation (8Gy) group had
significantly higher levels of cysteine as compared to all the other groups.

2.4.5. Catalase, Glutathione Reductase and Caspase-3 Results. Table 2.1
displays the results of catalase, glutathione reductase, and caspase-3 activities as
determined using enzyme assays. The catalase activity was significantly higher in the
control as compared to the treatment groups. The single agent treatment groups had
significantly higher catalase activity compared to that in the combined exposure groups.
Glutathione reductase and caspase-3 activities were significantly higher in the combined
exposure groups than those in both the single agent exposure groups and the control.

Table 2.1. CAT, GR, and CAS-3 activities.

Groups

CAT (mU/mg pro)

GR (U/mg pro

CAS-3

Control

2.47± 0.21

40.13 ± 2.44

0.262 ± 0.012

EtOH

1.4 ± 0.12*/**

45.43 ± 2.59*/**

0.325 ± 0.037*/**

XRT

1.65 ± 0.15*/**

47.4 ± 2.89*/**

0.366 ± 0.045*/**

XRT + EtOH

1.16 ± 0.09*

51.15 ± 1.12*

0.661 ± 0.027*

All the experiments were performed in triplicate, and the values reported are mean ± SD.
*
p < 0.05 compared to corresponding value of control group, ** p < 0.05 compared to
combined exposure group.
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2.4.6. MDA and MTS Results. Table 2.2 shows the results of ethanol and
radiation exposure on MDA and MTS. The level of MDA, a marker of lipid peroxidation,
was measured by using the HPLC method. The combined exposure groups had
significantly higher MDA levels than both the single agent exposure and the control
groups. Treating HepG2 cells with ethanol, and then exposing them to radiation, elevated
MDA levels far beyond the levels obtained in the control, ethanol only, or radiation only
groups. Metabolically active cells bioreduce the MTS to a colored formazan product in
the culture media. The number of viable cell is determined by measuring the absorbance
at 490 nm. A decrease in absorbance indicates less viability. The number of viable cells,
as determined by the MTS assay was significantly higher in the control than in both the
single agent exposure and the combined exposure groups. The single agent exposure
groups had significantly higher cell viability than the combined exposure groups. The
free radicals produced by irradiation attack on polyunsaturated fatty acids (PUFA) leads
to the formation of MDA, along with other products. Ethanol increases the levels of
CYP2E1 by a post-transcriptional mechanism, leading to the formation of stable adducts.
During its catalytic cycle, CYP2E1, which has high NADPH oxidase activity [96],
generates ROS and hydrogen peroxide, and in the presence of iron, Fenton reaction takes
place, producing more harmful free radicals such as hydroxyl radicals, ferryl species, and
1-hydroxyethyl radicals. These ROS damage the cell membranes through lipid
peroxidation and the production of lipid aldehydes such as MDA and 4-hydroxynonenal.
Increased levels of MDA is an indicator of elevated toxicity.
2.4.7. Detection of Apoptosis in HepG2 Cells. Figure 2.9 (panels A through D)
shows the images of HepG2 cells that were treated with 50 mM ethanol, 8 Gy radiation,
50 mM ethanol and 8 Gy radiation for induction of apoptosis, and blank control.
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Table 2.2. MTS and MDA results.

Groups

MTS (% untreated control)

Control

100 ± 9.8

22.8± 1.83

EtOH

84.5 ± 6.39*/**

27.9 ± 1.55*/**

XRT

72.8 ± 9.46*/**

24.7 ± 2.06*/**

XRT + EtOH

60.4 ± 4.8*

29.5 ± 2.23*

MDA (nmol/100 mg pro)

The experiments were performed in triplicate, and values presented as mean ± SD. * p <
0.05 compared to corresponding value of control group, ** p < 0.05 compared to
combined exposure group.

The cells were observed using a fluorescent light microscope, with a differential
uptake of fluorescent DNA binding dye (AO/EB dye mix). Acridine orange (AO)
permeates all cells and makes the nuclei appear green, while ethidium bromide (EB) is
taken up only by cells that have lost cytoplasmic membrane integrity, and stains the
nuclei red. Panel A shows images of control group cells, with most of the cells stained
green, indicating that there is little apoptosis taking place in the control group. Panel B
cells were treated with 50 mM ethanol, while panel C cells were treated with radiation
(8Gy). In both panels, there is evidence of increased apoptosis because of the number of
cells with highly condensed red/orange nuclei. Panel D cells were exposed to 50 mM
ethanol, followed by radiation (8 Gy). There is a significantly elevated level of apoptosis
in this group as compared to both the control and the single agent exposure groups, as
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evidenced by the number of red/orange-stained cells with highly condensed chromatin
matter.

A) Control

B) EtOH (50 mM)

C) XRT (8Gy)

D) EtOH (50 mM) + XRT (8Gy)

Figure 2.9. Morphological changes in different treatment groups of HepG2 cells.
The cells were treated as described in the method section, washed with cold PBS, and
stained with AO/EB dye mixture, and then observed using a fluorescent microscope
(original magnification 400x). (A) Microphotograph of blank control HepG2 cells,
incubated with the media only. The normal non-apoptotic cells were dyed green, while
apoptotic cells, with highly condensed chromatin material, were dyed red with the
AO/EB dye mixture. (B) HepG2 cells treated with 50 mM ethanol. There are more
apoptotic cells compared to the control group. (C) HepG2 cells exposed to radiation (8
Gy). The number of apoptotic cells is comparable to that in the ethanol treated group, but
significantly higher than the number in the control group. (D) The group treated with 50
mM ethanol for 24 h, then exposed to radiation (8 Gy). The number of apoptotic cells is

48
higher than that in both the control and the single agent treatment groups. Apoptosis was
induced more by combined exposure than by single agent exposure.

2.5. DISCUSSION
This investigation reports on the in vitro assessment of the toxic effects of ethanol
and ionizing radiation on HepG2 cells by measuring antioxidant levels and antioxidant
enzyme activities. Consumption of ethanol is widespread and many cancer patients who
undergo radiotherapy have consumed ethanol at one time or another. In a majority of
cases, it has been assumed that consumption of ethanol will not affect the outcome of
radiotherapy, in spite of the well known fact that both ethanol and radiation produce free
radicals that can be very damaging to tissues. Radiation oncologists who administer
radiotherapy are, for the most part, not aware that significant alcohol consumption is a
possible predisposing conditions that could potentially endanger the lives of patients.
Most investigations on the effects of ethanol and radiation on biological systems have
focused on single agent treatments. A few combined exposure studies have been reported,
including tobacco and radiation [82], but most investigations have concentrated on
radiation and other chemical agents [83-85]. Moreover, the end points measured in these
studies were biological or clinical outcomes such as radiosensitization, radiation
protection or tumor induction, not antioxidant status.
No study has been conducted to determine the toxic effects of exposure to
ethanol, followed by ionizing radiation in a model system, such as HepG2 cells. The aim
of this investigation was to determine the mechanism of toxicity of combined exposure to
ethanol, followed by radiation, and show that the toxicity of ethanol enhances the toxicity

49
of ionizing radiation in vitro. Linear decreases in GSH levels with increases in ethanol
concentrations and radiation doses were established, leading to the choice of an ethanol
concentration of 50 mM and a radiation dose of 8 Gy to be used for the rest of the
experiments.
2.5.1. Effects of Combined Exposure on GSH Levels. The results showed that
the levels of GSH in HepG2 cells exposed to ethanol followed by ionizing radiation were
significantly lower than GSH levels in cells exposed to ethanol or radiation only. GSH is
present in all mammalian cells and is a powerful antioxidant that scavenges free radicals
and hydrogen peroxide, and neutralizes toxic metabolites by condensing with them both
enzymatically and nonenzymatically [86]. GSH is found in both the cytosol and
mitochondria of cells. Most ROS are formed in the mitochondria during tissue respiration
as a result of leakage of electrons through the mitochondrial electron transport chain.
Neuman et al. have reported a dramatic decrease in mitochondrial GSH in isolated
hepatocytes exposed to alcohol [87]. Cytotoxicity of ethanol has been attributed to GSH
depletion according to studies conducted by Hirano et al. [88]. Devi et al. reported that
exposure of rat hepatocytes to ethanol increased ROS production, decreased GSH, and
increased lipid peroxidation [89].

Incubation of HepG2 cells with ethanol induces

oxidative stress and leaves the cells vulnerable to further injury by ROS. When cells are
exposed to ionizing radiation after ethanol exposure, they are not able to cope with
elevated levels of ROS. In conditions of severe oxidative stress, the ability of the cells to
reduce GSSG to GSH is overcome, leading to GSSG accumulation within the cytosol. To
prevent a shift in a cell’s redox equilibrium, GSSG is actively exported out of the cell or
reacted with the protein sulfhydryl group, producing mixed disulfide. Under such
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circumstances, GSH is not regenerated; thus depletion of cellular GSH can be potentiated
by severe oxidative stress [90]. This explains the significant decreases in the GSH levels
in the combined exposure groups as compared to single agent exposure, suggesting that
exposure to ethanol enhances the toxicity

of ionizing radiation through hightened

oxidative stress.
2.5.2. MDA Levels. Significantly higher levels of MDA were identified in the
HepG2 cells in the combined exposure groups as compared to both the control and the
single agent exposure groups. MDA is a marker of lipid peroxidation [91] and there are
numerous reports on induction of lipid peroxidation by both ethanol and radiation [9295]. The free radicals produced by irradiation attack on polyunsaturated fatty acids
(PUFA) leads to the formation of MDA, along with other products. Ethanol increases the
levels of CYP2E1 by a post-transcriptional mechanism, leading to the formation of stable
adducts. During its catalytic cycle, CYP2E1, which has high NADPH oxidase activity
[96], generates ROS and hydrogen peroxide, and in the presence of iron, Fenton reaction
takes place, producing more harmful free radicals such as hydroxyl radicals, ferryl
species, and 1-hydroxyethyl radicals. These ROS damage the cell membranes through
lipid peroxidation and the production of lipid aldehydes such as MDA and 4hydroxynonenal. Increased levels of MDA is an indicator of elevated toxicity.
2.5.3. GR and Caspase-3 Activities. Levels of glutathione reductase and
caspase-3 activities were more elevated in the combined exposure groups than those in
the single agent treatment groups. Previous investigations have reported that both ethanol
and radiation increase the activities of these enzymes [97-101]. The hydrogen peroxide
produced by ethanol metabolism and ionizing radiation is metabolized by GSH
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peroxidase (GPx) in the cytosol and by catalase in the peroxisomes. Metabolism of
hydrogen peroxide by GPx consumes GSH and produces GSSG. GPx then converts
GSSG back to GSH, at the expense of NADPH, to restore the cells’ redox status. Under
conditions of elevated levels of ROS, more GSH is consumed and considerable GSSG is
produced. The activity of GR increases to cope with the enormous amount of GSSG
being produced. Changes in the levels of caspase-3 are discussed further under detection
of apoptosis by EB/AO staining.
2.5.4. Catalase Activity. The results showed significant decreases in catalase
activity in all treatment groups, as compared to the control groups. Additionally, the
combined exposure groups had significantly lower catalase activity than that in the single
agent exposure groups. This is in agreement with findings of previous investigations
which have reported decreases in catalase activity, due to exposure to ethanol and
ionizing radiation [102-105], and inactivation of catalase by superoxide radical [106].
Lipid peroxidation has been shown to damage membrane proteins, inactivating receptors
and enzymes. These observations are supported by the in vitro catalase activity results.
The elevated levels of ROS in the combined exposure groups produce the greatest toxic
effects on the catalase enzyme.
2.5.5. MTS Assay. The cell viability of HepG2 cells was reduced to the lowest
level in the combined exposure groups as compared to the control, and significantly
lower as compared to the single agent exposure groups. Previous studies have shown that
ethanol and radiation reduce cell viability [107-109]. The deleterious changes produced
by ROS in essential biomolecules (such as DNA, lipids, and proteins) in the cells
eventually lead to cell death, reducing cell viability. ROS induce oxidative damage to
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DNA, which suffers double and single strand breaks, deoxyribose damage, and base
modifications. The proteins and lipids undergo oxidation, forming lipid aldehydes (such
as MDA) and oxidized proteins. These alterations affect vital cellular functions and lead
to cell death. Our investigation showed that combined exposure has a greater toxic effect
on cell viability than single agent exposure does.
2.5.6. Cysteine Levels. The results of this investigation showed that CYS levels
significantly increased in the combined exposure group, but remained unchanged in the
radiation only group as compared to the control, and decreased significantly in the
ethanol only group. Increases in CYS levels could have resulted from the degradation of
GSH by the ectoenzyme, γ-glutamyltranspeptidase (GGT), located on the external surface
of certain cells. Degradation of GSH by GGT yields cysteinylglycine, which is broken
down by dipeptidase to produce CYS and glycine. The amino acid linkage in GSH is
such that glutamate and CYS are linked by a peptide bond through the γ-carboxyl group
of glutamate, instead of the usual α-carboxyl group. This amino acid linkage prevents
degradation of GSH by intracellular peptidases. The only enzyme capable of degrading
GSH is the extracellular enzyme, GGT [110]. Under normal conditions, GSH is
transported out of a cell by carrier-mediated transporters [111],

across the cell

membrane, to participate in the γ-glutamyl cycle for the regeneration of CYS. When
oxidative stress sets in, however, the cell membrane is destroyed through lipid
peroxidation and protein oxidation, releasing the cellular contents, including GSH.
2.5.7. Detection of Apoptosis by EB/AO Staining. Significantly more HepG2
cells were stained red/orange with EB/AO staining in the combined exposure groups than
there were in the single agent exposure groups or the control. Apoptotic cells have
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condensed or fragmented chromatin, which stain red/orange with EB/AO, while live cells
have normal nuclei with organized chromatin and stain green [112-113]. Damage to
mitochondrial membrane by ROS produced by both ethanol and ionizing radiation leads
to the releases of cytochrome c molecules from the mitochondria into the cytosol.
Proapoptotic enzymes, caspases, are activated by cytochrome c in the cytosol to trigger
the apoptotic process [114]. Studies have shown that decreases in the GSH levels in cells
triggers apoptosis. Another mechanism of apoptosis induction is the involvement of Fas
and Fas ligand. Fas is a receptor found on hepatocytes, and can interact with Fas ligand
found on the surface of certain T-cells to trigger chemical processes that lead to
apoptosis. The binding of Fas to Fas ligand to trigger the process of apoptosis is mediated
by ROS, like those produced by ionizing radiation and ethanol metabolism [115]. In this
investigation, combined exposure lead to greater elevated levels of apoptosis than did
single agent exposure, due to increased levels of ROS in the combined exposure groups.

2.6. CONCLUSION
The results of this investigation have shown that combined exposure of HepG2
cells to ethanol and ionizing radiation has a significantly greater toxic effect on cells than
single agent exposure does. Since both ethanol and ionizing radiation have been proven
to produce free radicals in biochemical environments, it seems reasonable to suggest that
pre-radiation exposure of cells to ethanol induces oxidative stress in the cells, and leaves
them vulnerable to further attacks by ROS. When these cells are later exposed to ionizing
radiation, the antioxidant defense system is not able to withstand the renewed onslaught
of ROS, and more oxidative damage results. Therefore, it is concluded that a possible
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mechanism to account for enhanced toxicity of ethanol and ionizing radiation on HepG2
cells is through increased oxidative stress. This investigation could be an eye-opener for
doctors and oncologists to consider recent drinking histories of cancer patients before
radiotherapy is administered. Combined exposure studies are relevant since the
environment contains many diverse agents that can enter the biological systems, and
interact with each other leading to greater toxic effects.
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3. EFFECTS OF COMBINED EXPOSURE TO ETHANOL AND IONIZING
RADIATION ON THE ANTIOXIDANT STATUS OF AN IN VIVO MODEL

3.1. INTRODUCTION
The data from the in vitro investigation showed that combined exposure to
ethanol and ionizing radiation results in significantly higher oxidative stress compared to
single agent exposure [116]. Numerous investigations have shown that ethanol and
ionizing radiation can individually induce a state of oxidative stress in biological systems
through increased production of reactive oxygen species (ROS), such as

hydrogen

peroxide (H2O2), hydroxyl radical (•OH), superoxide radical (O2•-), and many other types
of ROS, proteins and lipid aldehydes [117-123].
Ethanol metabolism by the enzyme cytochrome P4502E1 (CYP 2E1) is well
documented to induce the production of reactive oxygen species [124-127]. This pathway
has been identified as the central pathway by which ethanol produces free radicals and
pathological transformations that are associated with chronic ethanol intake [128-129].
Moreover, investigators have found a positive correlation between increased levels of
CYP 2E1 and heightened deleterious changes in organs such as the liver [130].
Additionally, enzymatic metabolism of ethanol by alcohol dehydrogenase and
acetaldehyde dehydrogenase enzymes result in increased levels of NADH, which induce
the conversion of xanthine dehydrogenase (XDH) to xanthine oxidase (XO), and
subsequent generation of free radicals [131]. Non-enzymatic metabolism of ethanol
generates α-hydroxyethyl radical (CH3C•HOH), which can react with oxygen to form a
peroxy radical intermediate, which then undergoes rearrangement to produce
acetaldehyde and superoxide radical. The ROS produced during enzymatic and non-
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enzymatic ethanol metabolism proceed to attack cellular components such as cell
membranes, mitochondrial membranes, and DNA, resulting in protein oxidation, lipid
peroxidation, breaks in single and double stranded DNA, and tissue damage.
Ionizing radiation is known to produce tissue damage through direct ionization by
energy transfer of the atoms comprising the targeted proteins, lipids, and DNA [132].
Radiation-induced DNA damage has been reported in rats and mice by many
investigators [133]. Interaction of ionizing radiation with water molecules, which
constitutes up to 80% of the cells in the living organisms, results in the fission of O-H
bonds in water to produce hydrogen (H•) and hydroxyl (•OH) radicals. Hydroxyl radical
is the most lethal of all the ROS formed from radiolysis of water molecules, and reacts at
a diffusion-controlled rate with the majority of the molecules in the living cells [134]. It
is commonly believed that most, if not all, of the deleterious effects of exposure to
ionizing radiation in the living systems are initiated by the attack of

•

OH on

carbohydrates, lipids, proteins, and DNA molecules [135], resulting in loss of cell
membrane integrity, lipid peroxidation, mitochondrial permeability transition, and
formation of other harmful adducts such as MDA and 4- hydroxynonenal (4-HNE).
Ethanol and ionizing radiation produce ROS in biological systems. Exposure of
an organism to certain levels of these agents simultaneously should be viewed as having a
potential to cause increased pathological damage. Due to increased application of
radiotherapeutic procedures to cancer patients, who may have other predisposing
conditions likely to negatively impact on the outcome of radiotherapy, it has become
necessary to engage in combined exposure studies to investigate how various agents and
conditions would interact with each other in model systems. In spite of widespread use of
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ethanol as an alcoholic beverage, and increased exposure to ionizing radiation in
radiotherapy situations, combined exposure investigations have not been performed. The
use of ethanol in the context of chronic heavy and light drinking, followed by exposure to
ionizing radiation, would model a cancer patient with a chronic heavy drinking recent
history undergoing radiotherapy. Furthermore, it is well documented that the risk of
serious complications following therapeutic irradiation is heightened by a variety of
predisposing conditions, including diabetes, ataxia telangiectasia, prior abdominal/pelvic
surgeries, and collagen vascular diseases such as scleroderma or lupus [136-139].
In this investigation the CD-1 mice were used to model chronic light and heavy
drinking followed by exposure to a sub-lethal dose of ionizing radiation, as would be the
case in a chronic alcohol user who undergoes therapeutic irradiation. The mice were
chronically exposed to low-dose (5%) ethanol or high-dose (10%) ethanol in their
drinking water for 6 weeks, followed by exposure to 8 Gy of ionizing radiation, before
being sacrificed 4 d later. To assess the effects of combined exposure on the mice,
various parameters were measured, including total blood count, GSH, CYS, GSSG, and
MDA levels, and the antioxidant activities of the enzymes catalase and glutathione
reductase.

3.2. EXPERIMENTAL DESIGN
3.2.1. Chronic Light Ethanol Treatment. The animals in this group received
ethanol in increasing concentrations, to a final concentration of 5% (v/v) ethanol solution
as their sole drinking fluid for 6 weeks.

58
3.2.2. Chronic Heavy Ethanol Treatment. The chronic high dose ethanol group
received ethanol in increasing concentrations to a final concentration of 10% (v/v)
ethanol solution as their sole drinking fluid. The ethanol treatment period lasted 6 weeks.
3.2.3. Exposure to Ionizing Radiation. The animals in the combined exposure
and radiation only groups were exposed to ionizing radiation in the middle of the 6 weeks
of treatment, as detailed under the material and methods section.
3.2.4. Oxidative Stress Studies. The antioxidant status of the animals was
determined by measuring the GSH, CYS, and GSSG levels, along with the activities of
some antioxidant enzymes (GR and CAT). MDA, which is a lipid peroxidation
biomarker, was also measured. The aim of these procedures was to determine how the
combined exposure to ethanol and radiation affected the antioxidant status of the mice (in
vivo model).

3.3. MATERIALS AND METHODS
3.3.1. Materials. HPLC-grade acetonitrile, glacial acetic acid, water, and
phosphoric acid, used for the preparation of the mobile phase, were purchased from
Fisher Scientific (Fair Lawn, NJ USA). N-(1-pyrenyl)-maleimide (NPM), used as a
derivatizing agent for measurement of CYS and GSH, 1,1,3,3-tetramethoxypropane, and
ethanol were purchased from Aldrich (Milwaukee, WI USA). Protein concentration was
evaluated with the Bradford reagent obtained from BioRad (Melville, NY USA). The
CD-1 mice were from our breeding colony (VA Medical Center, St Louis, MO USA).
Heparin was provided by Dr. Mark Ranney (University of MO-Rolla). Safety syringes
were purchased from Fisher Scientific (Fair Lawn, NJ USA).
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3.3.2. Animals. The mice were housed in a temperature-controlled (25oC) room,
that was equipped to maintain a 12 h light-dark cycle. Tap water and standard rat chow
(Purina rat chow) were given ad libitum for 3 weeks while the mice were being
acclimated before the experiments began. 40 mice were randomly divided into six groups
(6 or 7 animals per group), and housed 3 or 4 per cage in polycarbonate cages with
wooden chips as bedding. The groups were designated as follows: Group I (n=6): Control
(no exposure to ethanol or XRT); Group II (L-EtOH) (n=6): Chronic low-dose ethanol
(5% v/v ethanol in the drinking water); Group III (H-EtOH) (n=7): Chronic high-dose
ethanol drinking (10% v/v ethanol solution as the sole drinking fluid); Group IV (XRT)
(n=7): Radiation only (8 Gy XRT); Group V (L-EtOH + XRT) (n=7): Chronic low-dose
ethanol drinking (5% v/v ethanol solution) and 8 Gy XRT; Group VI (H-EtOH + XRT)
(n=7): Chronic high-dose drinking (10% v/v ethanol solution) and 8 Gy XRT. The same
treatments were continued after the mice were irradiated until the day of sacrifice. All of
the procedures performed with the animals were approved by the University of Missouri
– Rolla Animal Care and Use Committee
3.3.3. Exposure of Animals to Ethanol. The control group mice were kept for
the same period as the treatment groups, but were fed only the mouse food and tap water.
The chronic low-dose ethanol drinking groups received 2% (v/v) ethanol solution diluted
from 99.8% ethanol as their only drinking fluid for 3 days, followed by a 4% ethanol
solution (v/v) for 4 days. Finally, a 5% (v/v) ethanol solution was provided for the next 5
weeks to complete the chronic drinking treatment period. The chronic high-dose ethanol
drinking treatment groups received a 2% (v/v) ethanol solution as their only drinking
fluid for 3 days, followed by 4% for the next 3 days, 6 % for 3 days, and 8 % for another
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5 days. Finally, a 10 % (v/v) ethanol solution was provided for the next 4 weeks to
complete the chronic drinking treatment period. 3 % (w/v) food grade white sugar was
added to the drinking fluids of both the control and the treatment groups to improve the
palatability of the ethanol solutions. The average peak ethanol intake was 5.4g/kg body
weight for the chronic low-dose ethanol drinking groups, and 11.2g/kg body weight for
the chronic heavy ethanol drinking groups.
3.3.4. Exposure of Animals to Ionizing Radiation. At the end of the ethanol
treatment period, the mice in the combined exposure groups and the radiation only groups
were exposed to radiation. The animals were exposed to 8 Gy of radiation at a dose rate
of 3 Gy/min using a 9 MeV beam generated by a Varian Linear accelerator, model 21 EX
(Varian Associates, Walnut Creek, CA, USA), at the Radiation Oncology Department of
the Phelps County Regional Medical Center in Rolla, Missouri, USA. A 25 x 25 cm field
was used, and output factors were checked once a week. Flatness of the field was also
checked once a week and was maintained within 2 %. A 25 x 25 cm field showed the
90% isodose at 2.75 cm depth. The 95% fall-off point was at 2.5 to 2.6 cm depth. Less
than 10% dose variation through the thickness of a mouse was achieved under these
conditions. All of the animals were anesthetized and heparinized blood was collected via
cardiac puncture 4 days after radiation treatment. After perfusion with an antioxidant
buffer, the livers were removed. The blood samples were kept on ice or at 4-8oC, and
taken to the University of Missouri-Columbia, Research Animal Diagnostic Laboratory
(RADIL) the very next day for complete blood count analysis. The liver tissue samples
were analyzed immediately for GSH, CYS, and GSSG levels and the remaining samples
were kept in a -80 oC freezer for later analysis.
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3.3.5. Preparation of Tissue Homogenates. The tissue samples from the livers,
kidneys, and brains of the mice were homogenized (0.15 g/ml) in antioxidant buffer to
avoid oxidation. The antioxidant buffer was prepared by dissolving 1.2 g disodium
phosphate, 0.32 g sodium dihydrogen phosphate, 100 µL butylated hydroxytoluene
(BHT) solution (0.1102 g BHT in 1 mL 100 % ethanol), 0.841 g aminotriazole, 0.039 g
DETAPAC, and 0.065 g sodium azide in 1 L HPLC-grade water.
3.3.6. Determination GSH and CYS. Tissue levels of GSH and CYS were
determined by RP-HPLC, according to the method developed by Winters (Winters et al.,
1995). The HPLC system (Thermo Electron Corporation) consisted of a Finnigan Spectra
System vacuum membrane degasser (model SCM1000), gradient pump (model P2000),
autosampler (model AS3000), and fluorescence detector (model FL3000) with λex =
330nm and λem = 376nm. The HPLC column was a Reliasil ODS-1 C18 column (5 µm
packing material) with 250 x 4.6 mm (Column Engineering, Ontario, CA, USA). The
mobile phase was 70% acetonitrile and 30% water and was adjusted to a pH of 2 with
acetic acid and o-phosphoric acid. The NPM derivatives of CYS and GSH were eluted
from the column isocratically at a flow rate of 1mL/min.
3.3.7. Determination of Oxidized Glutathione (GSSG). Straight tissue
homogenate (84 µL) was mixed with 16 µL of 2-vinyl pyridine and incubated for 1 h at
room temperature to block the preexisting GSH. At the end of the incubation period, 95
µL of 2 mg/ml solution of NADPH and 5 µL of a 2 units/ml glutathione reductase
enzyme were added to the tissue homogenate and mixed. An aliquot (100 µL) of this
mixture was removed and mixed with 150 µL of HPLC grade water and 750 µL of NPM
(1 mM in acetonitrile). This mixture was incubated for 5 min at room temperature, after
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which 5 µL of 2N HCl was added to stop the reaction. The samples were filtered into
vials through 0.2 µm filters and injected into the HPLC system.
3.3.8. Determination of Malondialdehyde (MDA). The MDA determination
was done by the RP-HPLC method using λex = 515 nm; the λem 550 nm (Gutteridge,
1975). Tissue homogenate (350 µL) was mixed with butylated hydroxytoluene (BHT)
(100 µL of 500 ppm solution) and 10% trichloroacetic acid (550 µL), and boiled for 30
min. After the solution was cooled on ice and centrifuged for 10 min at 1500 xg, the
supernatant (500 µL) was mixed with thiobarbituric acid (500 µL). The tubes were boiled
again for 30 min, and then cooled on ice. A solution (500 µL) was added to n-butanol
(1.0 ml), vortexed, and centrifuged for 5 min at 60 xg to facilitate a phase separation. The
top layer was then filtered through 0.2 μm filters and injected onto a 5 μm C18 column
(250 x 4.6 mm) on a RP- HPLC system. The mobile phase consisted of 69.4% 5mM
sodium phosphate buffer pH = 7.0, 30% acetonitrile, and 0.6% tetrahydrofuran.
3.3.9. Glutathione Reductase (GR) Activity Determination. Glutathione
reductase (GR; EC 1.6.4.2) activity was measured spectrophotometrically at 340 nm
following the decrease of NADPH using a commercial kit from OxisResearch™
(Portland, Oregon, USA). This reaction maintains the normal levels of cellular
glutathione, essential for keeping the levels of free radicals and organic peroxides down.
3.3.10. Catalase (CAT) Activity Determination. The activity of catalase (CAT;
EC 1.11.1.6) in the cell homogenates was measured spectrophotometrically at 240 nm
following the exponential disappearance of hydrogen peroxide (H2O2; 10 mM) according
to the method described by Aebi (Aebi, 1984). The catalase activity was calculated from
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A60 = Ainitial e-kt where k, is the rate constant, Ainitial , is the initial absorbance, and A60 is
the absorbance at 60 s.
3.3.11. Total Blood Count. Immediately following blood collection, with a 23 g
needle into a heparinized syringe, peripheral blood smears were made on microscope
slides, according to the standard operating procedure set by the Research Animal
Diagnostic laboratory (RADIL) of the University of Missouri-Columbia, USA. 500 µL of
whole blood in Ependorf tubes on ice, together with the blood smears, were taken to MU
RADIL for complete blood count analysis. All of the red blood cell and platelet
parameters were measured by an automated hematology instrument (Abbott Cell-Dyn
3500 Hematology analyzer, Abbott Labs., Abbott Park, IL, USA). White blood cell
counts, including a differential count, were also measured. White blood cell differentials
were obtained from blood smears prepared at the time of blood collection.
3.3.12. Protein Determination. A Hitachi U-2000 double beam UV-Vis
spectrophotometer (Tokyo, Japan) was used to measure protein concentration using the
Bradford assay (Bradford, 1976) and antioxidant enzyme activities.
3.3.13. Statistical Analysis. Means are reported with their standard deviations. The
results were analyzed with the student’s t-test when only two means were compared and
by one-way analysis of variance (one-way ANOVA) to assess the significance of the
difference between the control and the treatment groups, and between the single agent
exposure and combined exposure groups. Calibration curves were plotted and linear
equations from the calibration standards were used to determine the parameters to be
measured. P < 0.05 was considered significant.
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3.4. IN VIVO RESULTS
3.4.1. Weight Changes During the Treatment Period. The mice were weighed
on a weekly basis to monitor changes in weight in each group. The results of the weight
changes are shown in Figures 3.1 to 3.6. There were increases in weight in all the groups
during the 41 d treatment period, but the control group had the most steady weight
increase, and higher weight gain as compared to the rest of the groups. All the ethanol
treatment groups had similar patterns in weight fluctuations, and comparable weight
changes. There was a drop in the weight of the mice in all the groups that were irradiated,
starting from the day of irradiation. The radiation only group had the sharpest drop in
weight.
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Figure 3.1. Weight changes in mice of the control group.
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The mice were kept for 6 weeks, and were provided food and water ad libitum. There was
a steady increase in weight in all the mice in the control group. (C: control, C1, C2, C3,
C4, C5, C6 represent each control animal).
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Figure 3.2. Weight changes in mice treated with light/low-dose ethanol.
The mice were provided the ethanol (5% v/v) solution as their only drinking fluid, and
rodent food ad libitum. There were fluctuations in weight during the treatment period, but
the general trend was a gradual increase. (L: light/low-dose ethanol treatment, L1, L2, L3,
L4, L5, L6 represent each animal in the light/low-dose ethanol treatment group)
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Figure 3.3. Weight change in the heavy/high-dose ethanol group.
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The mice in this group were given ethanol solution at a final concentration of 10 % (v/v),
and the treatment lasted 6 weeks. There were fluctuations in weght during the treatment
period, but the trend was a gradual increase. (H: heavy/high-dose ethanol treatment,
H1,H2, H3, H4, H5, H6, H7 represent each animal in the heavy/high-dose ethanol treatment
group).

50
48

Weight (g)

46

X1

44

X2

42

X3

40

X4
X5

38

X6

36

X7

34
32
30
1

8

15

23

31

38

42

Days of treatment

Figure 3.4. Weight changes in the mice of the radiation only group.
The mice were provided food and water ad libitum for six weeks, and were exposed to 8
Gy of ionizing radiation on the 38th day. There was a steady increase in weight up to the
38th day, but the weight dropped sharply after the exposure to radiation. (X: radiation
only, X1-X7 represent animals in the XRT only group)
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Figure 3.5. Weight changes in light/ low-dose ethanol and radiation group.
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The entire treatment period was 6 weeks (42 d). Food and ethanol solution (5% v/v), as
the only drinking fluid, were given ad libitum. There were fluctuations in weight, but the
trend was that of a gradual increase up to the 38th day, then the weight dropped. (LX:
light/low-dose ethanol + XRT, LX1-LX7 represent all the animals in the light/low-dose
ethanol combined exposure group).
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Figure 3.6. Weight changes in heavy/high-dose ethanol combined exposure group.
The mice were given ethanol solution at a final concentration of 10 % (v/v) as their only
drinking fluid, and rodent chow ad libitum for 38 days, then exposed to 8 Gy of ionizing
radiation. There were fluctuations in weight, but the general trend was that of an increase
up to the 38th day, followed by a decrease. (HX: heavy/high-dose ethanol + XRT
treatment, HX1-HX7 represent all the animals in the heavy/high-dose ethanol combined
exposure group).

3.4.2. Percentage Weight Gain up to the 38th Day. The percentage weight gain
in each of the experimental groups are shown in Figure 3.7. The weight gain percentage
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was determined by subtracting the initial weight of each animal from the weight on the
38th day, and expressing the difference as a percentage. The control group had a slightly
higher weight gain than the rest of the groups, but the difference was not significant. The
ethanol treatment groups had comparable percentage weight gain.
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Figure 3.7. Percentage weight gain in grams in each group up to the 38th day.
There were weight gains in each group, which averaged 10 to 15 grams. The control
group gained a little more weight than the ethanol treatment groups. The percentage
weight gains in all the ethanol treatment groups were not significantly different. (HEtOH: heavy/high-dose ethanol treatment group, L-EtOH: light/low-dose ethanol
treatment group, H-EtOH + XRT: high-dose ethanol combined exposure, L-EtOH +
XRT: light-dose ethanol combined exposure)

3.4.3. Daily Fluid Intake. The average daily fluid in take of the mice during the
treatment period are shown in Figures 3.8 to 3.11. There were fluctuations within a
narrow range in the daily fluid intake of the mice in all the groups. The control group had
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a slightly higher fluid intake than the ethanol treatment groups. The light/low-dose
ethanol groups had slightly higher, but insignificant fluid intake as compared to the

Volume of fluid (ml)

heavy/high-dose ethanol treatment group.
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Figure 3.8. Daily fluid intake for the control group.
The fluid intake was measured after every 24 h for 41 d. The volume taken by each
mouse in the control group fluctuated within a narrow range. The control group had
insignificantly higher fluid intake as compared to the ethanol treatment groups.
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Figure 3.9. Daily fluid intake for the light/ low-dose ethanol treatment group.
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The volume of drink was measured after every 24 h. The mice were provided ethanol
solution (5% v/v) as their only drinking fluid. The drinking pattern fluctuated within a
narrow range.
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Figure 3.10. Daily fluid in take for the mice in heavy/high-dose ethanol group.
The mice were provided ethanol solution (10 % v/v) as their only drinking fluid. The
mice in this group had the lowest fluid in take, but the difference was insignificant
compared to the other groups.
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Figure 3.11. Daily fluid intake for the mice in the radiation only group.
Water was provided ad libitum, and the volume of drink was measured after every 24 h.
The volume taken by each mouse fluctuated within a narrow range.
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3.4.4. Complete Blood Count Results. Table 3.1 displays the protein content and
the white blood cell parameters (WBC numbers, neutrophils, lymphocytes, monocytes,
eosinophils, and basophils) obtained from manual differential data using the blood smears
that were prepared from the blood of the mice immediately after sacrifice. The protein
content of the blood was significantly higher in the control group than that in both the
single agent and combined exposure groups. The combined exposure groups had lower
protein content as compared to the single agent exposure groups, except for the XRT
group, which had the lowest protein content. The number of white blood cells (WBC)
was significantly higher in the control compared to the single agent and combined
exposure groups, with the exception of the high-dose ethanol group. The high-dose
ethanol combined exposure group had the lowest number of WBC. The control and highdose ethanol groups had the same numbers of neutrophils, while the low-dose ethanol and
XRT groups had the lowest number. The numbers of neutrophils in the high-dose ethanol
combined exposure and XRT only groups were too few to be determined. The numbers
of lymphocytes, monocytes, and eosinophils in the high-dose ethanol combined exposure
and XRT only groups were too few to be determined, while the control had the highest
numbers and the low-dose ethanol combined exposure had the lowest. The high-dose
ethanol group seemed to deviate from this trend, with numbers closer to those of the
control. The number of basophils was significantly higher in the control, as compared to
that of the single agent and the combined exposure groups. The combined exposure
groups had the lowest numbers of basophils.
The red blood cell and platelet parameters (RBC numbers, hemoglobin content,
hematocrit %, mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH),
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Table 3.1. Effects of ethanol and XRT on white blood cell parameters.
Total
pro
(g/dL)

Leucocytes
(x1.0+03/
µL)

Neutrophils
(x1.0+03/
µL)

Lymphocyte
s (x1.0+03/
µL)

Monocytes
(x1.0+03/
µL)

Eosinophils
(x1.0+03/
µL)

Basophils
(x1.0+03/ µL)

Normal
range

5.9 10.3

5.0 - 13.7

N/A

N/A

N/A

N/A

0.0 - 0.2

Control

6.3 ± 0.3

3.4 ± 1.0

0.4 ± 0.2

3.0 ± 0.8

0.08

0.05 ±
0.007

0.19 ± 0.03

L-EtOH

6.2 ± 0.8

1.0 ± 0.6*/**

0.2 ± 0.1*

0.9 ± 0.4*

0.06

0.02

0.04 ± 0.006*/**

H-EtOH

5.8 ± 0.6

3.9 ± 1.0**

0.4 ± 0.08

3.4 ± 0.9

0.12± 0.09

0.03

0.15 ± 0.08**

XRT

5.0 ± 0.9

0.3 ± 0.2*

0.0000

0.000

0.000

0.00

0.013 ± 0.005

L-EtOH
+ XRT

5.2 ± 0.4

0.7 ± 0.1*

0.16

1.7

0.12

0.00

0.01 ± 0.0

H-EtOH
+ XRT

5.5 ± 0.5

0.2 ± 0.06*

0.0000

0.000

0.000

0.00

0.01 ± 0.0

mean corpuscular hemoglobin concentration (MCHC), platelet numbers, and mean
platelet volume (MPV)) were obtained from automated differential data, which was
acquired on a Cell Dyne 3500 (Abbot) analyzer, are displayed in Table 3.2. The RBC
numbers, hemoglobin content, and hematocrit percentage were highest in the ethanol
only treatment groups, but lowest in the XRT only group. Nevertheless, all of these
parameters fell within the normal range in all the groups. The MCV and MCH were slowdosely higher in the control, but not significant when compared to the treatment groups;
the measurements for these parameters fell within the normal range in all of the groups.
There was no significant difference in MCHC in all of the groups. The number of
platelets was highest in the control and lowest in the XRT only group, but they were too
few to be counted in the high-dose ethanol combined exposure group. The MPV values
fell within the normal range in all of the groups, and were not significantly different from
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each other; values could not be determined for the high-dose ethanol combined exposure
group.

Table 3.2. Effects of ethanol and XRT on red blood cell parameters.

MCH (pg)

MCHC
(g/dL)

Plts
(x1.0+0
3/ µL)

MPV (fL)

45.4 60.3

14.1 - 19.3

30.2 34.2

5922972

5.0 - 20.0

44.5 ± 1.9

51.2 ± 0.9

16.6 ± 0.4

32.4 ± 0.7

960 ± 25

9.5 ± 1.2

15.8 ± 1.1

48.3 ± 4.0

49.2 ± 0.7

15.9 ± 0.2

32.3 ± 0.5

768

7.7 ± 0.4

10.4 ± 0.7

15.6 ± 0.6

48.7 ± 2.9

47.5 ±1.0

15.05 ± 0.5

31.8 ± 0.7

952 ± 92

8.9 ± 2.3

XRT

7.7 ± 0.7

12.4 ±
0.9*

37.2 ±
3.8*/**

48.8 ± 0.9

16.07 ± 0.4

32.9 ± 1.4

692 ±
36*

8.1 ± 1.6

L-EtOH
+ XRT

8.9 ± 0.8

14.2 ± 1.3

43.0 ± 4.9

48.6 ± 1.3

16.0 ± 1.7

32.9 ± 0.7

787

9.7 ± 1.0

H-EtOH
+ XRT

9.2 ± 0.6

14.2 ± 1.1

44.0 ± 3.6

48.2 ± 1.4

15.4 ± 0.2

31.8 ± 0.6

0.00

0.00

RBC
(M/µL)

Hb (g/dL)

Hem (%)

MCV (fL)

Normal
range

6.36 9.42

11.0 15.1

35.1 45.4

Control

8.9 ± 0.6

14.8 ± 0.7

L-EtOH

9.9 ± 0.7

H-EtOH

All of the red blood cell and platelet parameters were measured by an automated
hematology instrument (Abbott Cell-Dyn 3500 Hematology analyzer) at the UMC
Research Animal Diagnostic Laboratory (RADIL), Columbia, MO, USA. The number of
platelets and MPV could not be determined in the high-dose ethanol combined exposure
group. (Hb: hemoglobin, Plts: platelets, Hem: hematocrit)

3.4.5. Liver GSH Levels. The GSH levels in all the groups were determined
following homogenization of the liver tissue samples, and derivatization using NPM.
Figure 3.12 shows how the levels of GSH varied in the livers of mice that were treated
with low-dose ethanol and/or radiation. The GSH levels were highest in the control
group, and lowest in the combined exposure group (group treated with ethanol plus
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radiation exposure). The combined exposure group had significantly lower GSH levels
compared to the single agent exposure groups. The results for the GSH levels of highdose ethanol combined exposure groups are shown in Figure 3.13. The GSH levels in this
figure followed a pattern similar to that in Figure 3.5 (a), but the differences were larger.
Chronic high-dose ethanol combined with radiation exposure resulted in significantly
lower GSH levels than chronic low-dose ethanol combined with radiation exposure. In
both of these groups, combined exposure resulted in significantly lower GSH levels than
the control and single agent exposure groups. The high-dose ethanol combined exposure
group resulted in significantly lower GSH levels compared to low-dose ethanol combined
exposure group. The sample chromatograms shown in Figures 3.14 to 3.19 are from the
liver samples, with the area under the curve being largest in the control group and
smallest in the high-dose ethanol combined exposure group.
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Figure 3.12. GSH levels in the chronic low-dose ethanol groups (liver).
The mice were treated with ethanol (5%v/v) for 5 weeks, and then exposed to 8 Gy
radiation. The GSH levels were measured by the HPLC method after homogenization of
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the liver tissue samples and derivatization with NPM. The GSH levels were significantly
lower in the treatment groups as compared to the control. The combined exposure group
had a significantly lower GSH level as compared to the single agent treatment groups. *
Significantly different compared to control (p < 0.05). # Significantly different compared
to combined exposure group (p < 0.05). (H-EtOH: heavy/high-dose ethanol treatment
group, L-EtOH: light/low-dose ethanol treatment group, H-EtOH + XRT: high-dose
ethanol combined exposure, L-EtOH + XRT: light-dose ethanol combined exposure,
XRT: radiation only group, pr: protein)
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Figure 3.13. GSH levels in the high-dose ethanol groups (liver).
The mice were treated with ethanol (10 %v/v) for 5 weeks, and then exposed to 8 Gy
radiation. The GSH levels were measured as described above. The combined exposure
group had significantly lower GSH levels as compared to the control and single agent
exposure groups. (H-EtOH: heavy/high-dose ethanol treatment group, L-EtOH: light/lowdose ethanol treatment group, H-EtOH + XRT: high-dose ethanol combined exposure, LEtOH + XRT: light-dose ethanol combined exposure, XRT: radiation only group, pr:
protein)
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Figure 3.14. The control liver sample Chromatogram.
The animals in the control group were not exposed to ethanol or radiation. Food and tap
water was provided ad libitum. Separation conditions: An ODS-1 C18 Column (5 µm
packing material) with 250 x 4.6 mm (i.d) was used for the separation. The NPM
derivatives were measured by a fluorescence detector (λex = 330 nm and λem = 376 nm).
Flow rate was 1ml/min.The GSH peak at a retention time of 8.20 min was the highest,
and the CYS peak was at the retention time of 10.73 min. The hydrolysis peak (due to
excess NPM) came earlier than the analyte peaks.
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Figure 3.15. The light/low-dose ethanol group liver sample Chromatogram.
The separation conditions were the same as mentioned in Figure 3.14.
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Figure 3.16. The high-dose ethanol group liver sample Chromatogram.
The mice received ethanol (10% v/v) solution as their only drinking fluid.
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Figure 3.17. The radiation only group liver sample chromatogram.
The mice received the same treatment as the control, but were exposed to the radiation at
the end of the treatment period.
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Figure 3.18. The light-dose ethanol combined exposure group chromatogram (liver).
The separation conditions were the same as described in Figure 3.14.
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Figure 3.19. The high-dose ethanol combined exposure group chromatogram (liver).
The separation conditions were the same as described in Figure 3.14.
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3.4.6. Brain GSH Levels. The results of the brain GSH levels displayed in
Figures 3.20 and 3.21, show that the control group had the highest GSH level; while
high-dose ethanol combined exposure group had the lowest GSH levels. The single agent
treatment groups had significantly higher GSH levels than the combined exposure
groups. The GSH levels in the liver were significantly higher than the GSH levels in the
brain in all the experimental groups.
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Figure 3.20. The GSH levels in the chronic low-dose ethanol groups (brain).
The treatment of the mice and GSH determinations were done as described in Figure 3.5.
(a). (H-EtOH: heavy/high-dose ethanol treatment group, L-EtOH: light/low-dose ethanol
treatment group, H-EtOH + XRT: high-dose ethanol combined exposure, L-EtOH +
XRT: light-dose ethanol combined exposure, XRT: radiation only group, pr: protein)
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Figure 3.21. The GSH levels in the chronic high-dose ethanol groups (brain).
The treatment of the mice and GSH determinations were done as described in Figure 3.5.
(b). (H-EtOH: heavy/high-dose ethanol treatment group, L-EtOH: light/low-dose ethanol
treatment group, H-EtOH + XRT: high-dose ethanol combined exposure, L-EtOH +
XRT: light-dose ethanol combined exposure, XRT: radiation only group, pr: protein)

3.4.7. Liver cysteine levels. The results of the liver cysteine levels are shown
Figures 3.22 and 23. The cysteine levels in the chronic low-dose ethanol only group
(Group II) were the highest, whereas the high-dose ethanol combined exposure group
(Group VI) had the lowest CYS levels. Combined exposure groups (Groups V and VI)
had significantly lower cysteine levels compared to the single agent (Groups II, III, and
IV) exposure and control groups. The high-dose ethanol only group had similar CYS
levels as the control group.
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Figure 3.22. The liver CYS levels in low-dose ethanol groups.
The treatment of the mice and CYS determinations were done as described in Figure
3.12. (H-EtOH: heavy/high-dose ethanol treatment group, L-EtOH: light/low-dose
ethanol treatment group, H-EtOH + XRT: high-dose ethanol combined exposure, L-EtOH
+ XRT: light-dose ethanol combined exposure, XRT: radiation only group, pr: protein)
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Figure 3.23. The liver CYS levels in high-dose ethanol groups.
The treatment of the mice and CYS determinations were done as described in Figure
3.12. (H-EtOH: heavy/high-dose ethanol treatment group, L-EtOH: light/low-dose
ethanol treatment group, H-EtOH + XRT: high-dose ethanol combined exposure, L-EtOH
+ XRT: light-dose ethanol combined exposure, XRT: radiation only group, pr: protein)
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3.4.8. Brain and Kidney Cysteine Levels. The kidney and brain CYS levels are
displayed in Table 3.3. There was no consistent pattern in CYS levels in the kidney,
while the CYS levels in the brain decreased gradual from the control, which had the
highest level, to the high-dose ethanol combined exposure group, which had the lowest
CYS levels.

Table 3.3. The kidney and brain CYS levels.
GROUPS

Kidney CYS (nmol/mg pro)

Brain CYS (nmol/mg pro)

Control

8.4 ± 0.4

8.1 ± 1.2

L-EtOH

9.4 ± 1.7*

7.4 ± 1.9*/#

H-EtOH

6.7 ± 1.1*/#

6.8 ± 1.4*/#

XRT

9.1 ± 1.2*/#

6.7 ± 1.3*/#

L-EtOH + XRT

9.3 ± 1.5*

6.0 ± 1.7*

H-EtOH + XRT

8.1 ± 1.3

5.3 ± 1.1*

The treatment procedures and CYS determinations were done as described figure 3.5. a
and b. (pro: protein)

3.4.9. GSSG Levels in the Liver Samples. The same liver tissue samples used to
determine the GSH levels were derivatized and used for the determination of the GSSG
levels. This was done in order to facilitate the determination of GSH:GSSG ratio. Figures
3.24 and 3.25 shows the results of the GSSG levels in the two categories of the treatment
groups. In both of the treatment categories, the control group had the lowest GSSG level,
while the combined exposure groups had the highest GSSG levels. The single agent
exposure groups had significantly lower GSSG levels as compared to combined exposure
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groups. The high-dose ethanol combined exposure group had significantly higher GSSG
level than the low-dose ethanol combined exposure group.
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Figure 3.24. The GSSG levels in the chronic low-dose ethanol groups (liver).
The mice in this group received an ethanol solution (5% v/v) as their sole drinking fluid
for 5 weeks, and then were irradiated and sacrificed 4 d later. The GSSG levels were
determined by the HPLC method as described under the methods section. The control
group had the lowest GSSG level, while the combined exposure group had the highest
level. (H-EtOH: heavy/high-dose ethanol treatment group, L-EtOH: light/low-dose
ethanol treatment group, H-EtOH + XRT: high-dose ethanol combined exposure, L-EtOH
+ XRT: light-dose ethanol combined exposure, XRT: radiation only group, pr: protein)
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Figure 3.25. The GSSG levels in the chronic high-dose ethanol groups (liver).
The mice received an ethanol solution (10% v/v) as their sole drinking fluid. The GSSG
level was determined as described above. The combined exposure group had the highest
GSSG level. (H-EtOH: heavy/high-dose ethanol treatment group, L-EtOH: light/low-dose
ethanol treatment group, H-EtOH + XRT: high-dose ethanol combined exposure, L-EtOH
+ XRT: light-dose ethanol combined exposure, XRT: radiation only group, pr: protein)

3.4.10. GSH:GSSG Ratio in the Liver Samples. The GSH levels from the liver
samples were divided by the corresponding GSSG levels in order to determine the
GSH:GSSG ratio in the liver. The control group, with the highest GSH level, and the
lowest GSSG level, had the highest GSH:GSSG ratio as compared to the single agent and
combined exposure groups, as can be seen in Figures 3.26 and 3.27. In the single agent
exposure groups, low-dose ethanol treatment and XRT groups had nearly equal
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GSH:GSSG ratios, while the high-dose ethanol treatment group had the lowest ratio. The
high-dose ethanol treatment combined exposure group had a significantly lower ratio
compared to the low-dose ethanol combined exposure group.
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Figure 3.26. The GSH:GSSG ratio in the chronic low-dose ethanol groups (liver).
The ratio was determined after separately determining GSH and GSSG levels, and then
dividing the corresponding values of the two parameters. The highest GSH:GSSG ratio
was in the control group, while the combined exposure group had the lowest ratio.
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Figure 3.27. The GSH:GSSG ratio in the chronic high-dose ethanol groups (liver).
The ratio was determined as described above. The combined exposure group had the
lowest ratio.

3.4.11. Liver MDA Levels. The high-dose ethanol combined exposure group had
the highest MDA level, while the control group had the lowest MDA level, as can be seen
in Figures 3.28 and 3.29. The differences in the MDA levels of the control, low-dose
ethanol, and XRT only groups, were not significant. High-dose ethanol resulted in higher
MDA levels than low-dose ethanol treatment in the liver. The MDA levels in the high-
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dose ethanol combined exposure group were significantly higher than those in the highdose ethanol and radiation only groups.
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Figure 3.28. The MDA levels in the chronic low-dose ethanol groups (liver).
The MDA levels were measured by the reversed-phase HPLC method with fluorescence
detection. The mobile phase consisted of 69.4% 5mM sodium phosphate buffer pH = 7.0,
30% acetonitrile, and 0.6% tetrahydrofuran. The flow rate was 1ml/min. The MDA levels
were significantly higher in the treatment groups as compared to the control group. The
combined exposure group had significantly higher MDA levels as compared to the single
agent exposure groups.
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Figure 3.29. The MDA levels in the chronic high-dose ethanol groups (liver).
The combined exposure group had the highest MDA levels, while the control group had
the lowest.
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3.4.12. Catalase and GR Activities in the Liver. The results for the catalase and
glutathione reductase activities are displayed in Table 3.4. The activities of these
enzymes were determined by a spectrophotometric enzyme assay method. The activity of
catalase enzyme was the highest in the control group, and lowest in the high-dose ethanol
combined exposure group. The single agent exposure groups had significantly higher
catalase activity than the combined exposure groups. Between the combined exposure
groups, the high-dose ethanol combined exposure group had lower catalase activity as
compared to the low-dose ethanol combined exposure group. The glutathione reductase
activity was the lowest in the control group, and highest in the high-dose ethanol
combined exposure group. The single agent exposure groups had significantly lower GR
activities, as compared to the combined exposure groups. The high-dose ethanol
combined exposure group had significantly higher GR activity as compared to the lowdose ethanol combined exposure group.

Table 3.4. CAT and GR activities in the liver of CD-1 mice.
Groups

CAT (units/mg pro)

GR (units/mg pro)

Control

0.25 ± 0.07

23.0 ± 5.0

L-EtOH

0.16 ± 0.02 */#

28.0 ± 3.1*/#

H-EtOH

0.13 ± 0.03*/#

32.4 ± 4.2*/#

XRT

0.15 ± 0.04*/#

39.7 ± 4.9*/#

L-EtOH + XRT

0.13 ± 0.02*

52.0 ± 6.5*

H-EtOH + XRT

0.10 ± 0.02*

63.8 ± 5.4*

Effects of chronic ethanol treatment followed by radiation exposure on catalase
(CAT) and glutathione reductase (GR) activities in the liver of CD-1 mice. [CAT activity
was measured spectrophotometrically at 240 nm following the exponential disappearance

89
of hydrogen peroxide (H2O2; 10 mM) according to the method described by Aebi (Aebi,
1984), while GR activity was measured at 340 nm following the decrease of NADPH.
The values reported are mean ± SD. * p < 0.05 compared to the corresponding value of
the control, while # P < 0.05 compared to the corresponding value of the combined
exposure group.

3.5. DISCUSSION
It has been shown by many investigators that oxidative stress plays a major role in
many human pathological conditions such as cancer, diabetes, cardiovascular disease,
neurological disorders, ischemia/reperfusion, and many other diseases as well as in aging
[140-143]. Any agent that affects the antioxidant status of living systems, such as ethanol
and ionizing radiation, has the potential of producing a negative impact on the health
condition of an individual [144-146]. After the in vitro investigation showed that a
combination of ethanol and ionizing radiation induces elevated oxidative stress [116], the
in vivo investigation of combined exposure using a CD-1 mice model was performed.
This study reinforces the need to have a thorough background check on patients in terms
of their previous and current drinking behaviors by doctors and oncologists before
procedures such as radiotherapy are administered. Unfortunately, the risk assessment in
most cases is performed with an assumption that the agent being studied acts
independently of other agents, even though interaction studies have shown that, at high
exposures, the action of one agent can be influenced by simultaneous exposure to the
other agents [147]. Previous combined exposure studies involving radiation and other
agents have focused on the measurements of various end points, including lung cancer,
mutations, tumor incidence, liver carcinomas and foci, and many others, but not
antioxidant status [148-151]. In this study, therefore, the levels of reduced glutathione,
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which is the most important antioxidant in the living systems, having a thiol functional
group that enables it to scavenge free radicals and maintains the redox status of the cells
was measured. The GSSG levels were also measured, and the GSH:GSSG ratios, MDA
levels, and antioxidant enzyme activities (CAT and GR) as a way of determining how
combined exposure to ethanol, followed by ionizing radiation, affects the antioxidant
status of mice were determined . Since ethanol metabolism, which takes place primarily
in the liver is associated with most pathological conditions of the liver [152-154], all of
the parameters mentioned were determined for the liver. Additionally, the GSH and CYS
levels in the brains of the mice were determined, since ethanol has been documented to
cross the blood brain barrier [155-156], and CYS levels in the kidneys.
The GSH levels in the livers and brains of CD-1 mice were lowest in our chronic
high-dose ethanol combined exposure group, and highest in the control. The ROS and
free radicals produced during ethanol metabolism have been shown to cause oxidative
stress and lipid peroxidation in the liver and brain [157-159]. Lieber reported depletion of
hepatic GSH after chronic alcohol consumption in experimental animals and humans
[160], and Borek reported that radiation at doses used in radiotherapy depletes tissue
antioxidants such as alpha tocopherol, and Vitamins A, C and E [161]. An investigation
conducted by Zentella et al. [162] concluded that ethanol intoxication decreased GSH
levels. GSH performs many essential functions in cells, such as scavenging free radicals,
maintaining the essential thiol status of proteins by preventing oxidation of –SH groups
or by reducing difulfide bonds induced by oxidative stress, detoxifying electrophiles,
modulating critical cellular processes such as DNA synthesis and immune function, and
providing a reservoir for cysteine [163-166].

Here, chronic ethanol administration
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induced a state of oxidative stress in the mice, lowering the levels of antioxidants and
interfering with the normal functioning of the antioxidant enzymes. When the mice were
exposed to ionizing radiation, further oxidative stress resulted, since the antioxidant
levels were already too low to cope with the increased production of ROS. Antioxidants
and antioxidant enzymes form the defense system against oxidative damage by ROS in
biological systems [167]. When this defense system is broken, tissue damage and
pathological conditions result.
The result of this investigation showed that GSSG levels were significantly
higher in the high-dose ethanol combined exposure group as compared to both the control
and the single agent exposure groups. The hydrogen peroxide formed in the cells is
reduced by GSH in the presence of glutathione peroxidase enzyme to form water, and in
the process, GSH is oxidized to GSSG. The GSSG is then reduced back to GSH by
glutathione reductase enzyme at the expense of NADPH. This forms a redox cycle which
keeps the levels of GSSG low and maintains the equilibrium between oxidants and
antioxidants in the cell [168]. When the cells experience conditions of severe oxidative
stress because of chronic exposure to ethanol or ionizing radiation, their ability to reduce
GSSG back to GSH can be overcome, resulting in accumulation of GSSG within the
cytosol. The cells, therefore, have high GSSG levels and low GSH levels, resulting in a
low GSH:GSSG ratio. The results of this investigation showed that the GSH:GSSG ratio
was significantly lower in the combined exposure groups in comparison to the control
and the single agent exposure groups, suggesting that the GSH-GSSG redox cycle could
not cope with the substantial amounts of GSSG that were being formed to maintain the
oxidant-antioxidant equilibrium of the cells.
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The catalase activity in the livers of the mice in this study was significantly lower
in the combined exposure groups as compared to the control and single agent exposure
groups. The study conducted by Escobar et al. on superoxide dismutase and catalase
inactivation by singlet oxygen and peroxyl radicals showed that these ROS lowered the
activity of catalase [169]. Ribiere et al. have shown that ethanol administration lowers the
activity of the catalase enzyme [170], while Potier et al. reported a decrease in catalase
activity in ox liver by radiation [171]. The catalase enzyme, which is most abundant in
the liver, decomposes hydrogen peroxide to oxygen and water by a dismutation process.
The active sites of catalase enzyme is altered by reactive oxygen species, rendering them
unable to carry out their catalytic functions. The results showed that the increased levels
of ROS induced by exposure to ethanol and ionizing radiation significantly decreased the
activity of catalase in the liver.
Glutathione reductase activity was significantly higher in the liver of the mice in
the combined exposure groups as compared to both the control and the single agent
exposure groups. Studies have shown that exposure to both ethanol and ionizing radiation
increase the activity of GR [171-173]. GR catalyzes the reduction of oxidized glutathione
(GSSG) to reduced glutathione (GSH), maintaining adequate levels of reduced cellular
GSH in the glutathione redox cycle. This reaction requires one mole of NADPH as a
cofactor, which is oxidized to NADP+ for every mole of GSSG reduced, and two moles
of GSH are produced. When the cells are experiencing oxidative stress, more GSH is
consumed and large amounts of GSSG are produced. The activity of GR rises to cope
with the increased amounts of GSSG being produced. The highest activity of GR
observed in the liver of the combined exposure groups suggests that combined exposure
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induced greater oxidative stress in the liver than single agents did and most affected the
antioxidant status.
The liver cysteine levels in this study were lowest in the combined exposure
groups as compared to single agent and control groups, while the brain cysteine levels
showed gradual decrease from the control, which had the highest level, to the high-dose
ethanol combined exposure, which had the lowest level. CYS levels in the kidney showed
fluctuations, without any particular pattern. Wlodek et al. have reported a decrease in the
levels of cysteine in the livers of mice after chronic exposure to ethanol [174], and
Dewey et al. [175] have shown that interconversion of cysteine to cystine, which is an
oxidation process, is induced by X-rays, and can induce alterations in cysteine levels. The
low levels of cysteine in the livers of combined exposure groups as compared to the
control and the single agent exposure groups could have been orchestrated by exposure to
ethanol and ionizing radiation, both of which have been proved to induce ROS capable of
initiating the oxidation of cysteine. Fluctuations of cysteine levels in the brains and
kidneys could have been brought about by degradation of GSH, a process that is induced
by ROS, and by oxidation of cysteine to cystine.
The MDA data from this investigation showed that the high-dose ethanol
combined exposure group had the highest levels of MDA while the control group had the
lowest. Both ethanol and ionizing radiation have been individually shown to induce lipid
peroxidation, which is indexed by the increased levels of MDA [176-180]. Ethanol
metabolism is characterized by events such as acetaldehyde formation, CYP2E1mediated 1-hydroxyethyl radical formation, ROS production, increase in the
NADH/NAD+ ratio, causing the reduction of ferric iron to ferrous iron, with
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accompanying production of hydroxyl radicals. These events lead to lipid peroxidation
and production of MDA and 4-hydroxynonenal (4-HNE). The ROS produced by ionizing
radiation attack polyunsaturated fatty acids (PUFA) in the liver, producing MDA and
lipid peroxides. Exposure to ethanol, followed by radiation, enhanced the generation of
enormous amounts of ROS. These, in turn, attacked the cell membrane lipids,
mitochondrial membrane and other cellular organelles, forming lipid aldehydes and
peroxides. The data from the investigation supported this observation.
The findings from this investigation showed that all of the white blood cell
parameters were significantly lower in the high-dose ethanol combined exposure and
XRT only groups than in all of the other groups, while the control had the highest values,
with exception of the high-dose ethanol only group, which seemed to deviate from this
observation. The red blood cell parameters also followed this general trend, more
notably, the platelet and mean platelet volume values, which were lowest in the high-dose
ethanol combined-exposure group. The destructive effects of the ROS are more
pronounced on the DNA molecules, causing single and double strand breaks. Rapid
proliferation of the blood cells does not allow for the repair of the damaged DNA
molecules, resulting in heightened apoptosis. This explains the dramatic changes in the
white and red blood cell and platelet parameters after exposure to ethanol and ionizing
radiation.

3.6. CONCLUSION
This investigation has elucidated the effects of chronic ethanol exposure, followed
by ionizing radiation on CD-1 mice as a model in vivo system, completing the
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investigation on the effects of combined exposure to ethanol and ionizing radiation on
model in vitro and in vivo systems. The in vivo results are in agreement with the in vitro
data from all of the major parameters that were measured, confirming that there seems to
be an interaction between ethanol and ionizing radiation in the biological systems, which
is more significant with higher doses of radiation and ethanol. Based on these findings, it
would appear to be good practice by doctors and oncologists to seriously consider the
recent drinking histories of cancer patients before radiation therapy is administered. In
view of the fact that both ethanol and ionizing radiation have individually been shown to
induce oxidative stress in biological systems, a deliberate effort should be made to
educate patients on the potential dangers of these agents, particularly when present in
biological systems simultaneously. Further investigation of combined exposure that
would involve chronic ethanol intake, tobacco smoking, and ionizing radiation in a
clinical setup is recommended. This would model a chronic high-dose alcohol and
tobacco user who undergoes radiation therapy, and provide interesting data on combined
exposure.
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ABSTRACT
2-Mercaptoethylamine (cysteamine) is an aminothiol compound used as a drug
for the treatment of cystinosis, an autosomal recessive lysosomal storage disorder.
Because of cysteamine’s important role in clinical settings, its analysis by sensitive
techniques has become pivotal. Unfortunately, the available methods are either complex
or labor intensive. Therefore, we have developed a new rapid, sensitive, and simple
method for determining cysteamine in biological samples (brain, kidney, liver, and
plasma), using N-(1-pyrenyl) maleimide (NPM) as the derivatizing agent and reversedphase high performance liquid chromatography (HPLC) with a fluorescence detection
method (λex = 330 nm, λem = 376 nm). The mobile phase was acetonitrile and water
(70:30) with acetic acid and o-phosphoric acid (1 ml/L). The calibration curve for
cysteamine in serine borate buffer (SBB) was found to be linear over a range of 0-1200
nM (r2 = 0.9993), and in plasma and liver matrix, the r2 values were 0.9968 and 0.9965,
respectively. The coefficients of the variation for the within-run and between-run
precisions ranged from 0.68% to 9.90% and 0.63% to 4.17 %, respectively. The
percentage of relative recovery ranged from 94.1% to 98.6%.

Keywords: CSH; cysteamine; NPM, thiols; cystinosis; oxidative stress; HPLC; 2mercaptoethylamine
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INTRODUCTION
2-Mercaptoethylamine (cysteamine) is an aminothiol compound used as a drug
for the treatment of cystinosis [1]. The deficiency of a cystine carrier in the lysosomal
membrane leads to cystine accumulation within the lysosomes, ultimately crystallizing in
vital organs such as the liver, kidney, spleen, intestines, and cornea [2, 3]. The kidney is
most sensitive to cystine accumulation that causes renal tubular Fanconi syndrome to
develop in children 6 to 12 months of age [4, 5]. Cysteamine crosses the plasma and
lysosomal membranes and reacts with the crystallized cystine within the lysosomes to
form cysteine and cysteine-cysteamine mixed disulfides, which leave through the lysine
porter [6]. The thiol functional group in cysteamine makes it a potential antioxidant in
oxidative stress conditions such as after radiotherapy.
Because of cysteamine’s important role in clinical settings and its potential future
applications as an antioxidant, it has become necessary to develop an analytical method
for detecting cysteamine in biological samples. Various derivatizing reagents and
procedures have been described in the literature for cysteamine analysis [7-9]. These
procedures, however, are either complex or time-consuming, involving incubation of
samples in the dark, deproteinisation, coupled enzyme reactions, and pre-treatment of the
biological samples. We have, thus, developed a method that is simple, sensitive, and
rapid for analyzing cysteamine in tissues from the brain, kidney, liver, and plasma. In this
study, we have used N-(1-pyrenyl) maleimide (NPM), which has high affinity for free
thiols as the derivatizing agent [10]. The derivatization procedure does not require
previous extraction and takes place at room temperature with an incubation period of
only 5 min. The adduct formed is stable for at least 4 weeks at 4oC and reversed-phase
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HPLC is used for the quantitation. Various analytical methods have been cited in the
literature for the determination of cysteamine in biological fluids, such as ion exchange
column chromatography [11], high voltage electrophoresis [12], electrochemical
detection [13, 14], and gas chromatography with flame photometric detection [15].
However, these methods lack sensitivity and have generally not been used with tissue
samples to determine cysteamine. Because of this, we used reversed-phase HPLC with
fluorescence detection since this method is very sensitive and specific for NPM-thiol
adducts, in detecting and quantitating cysteamine in tissues of rats.

EXPERIMENTAL
Reagents and chemicals
Acetonitrile, acetic acid, and phosphoric acid (all HPLC grade) were purchased
from Fisher (Fair Lawn, NJ, USA). NPM and diethylenetriaminepentaacetic acid
(DETAPAC) were obtained from Aldrich (Milwaukee, WI, USA). Cysteamine and TrisHCl (Trizma hydrochloride), and all the other chemicals were obtained from Sigma (St
Louis, MO, USA).

Animals
Adult Sprague Dawley rats, weighing 250-280 g each, were obtained from
Charles River Laboratories (Wilmington, MA, USA). The rats were housed in a
temperature-controlled (25oC) room equipped to maintain a 12 h light-dark cycle.
Standard rat chow (Purina rat chow) and water were given ad libitum. After over-night
fasting, cysteamine was administered intraperitoneally at 300 mg/kg of body weight in 1
ml of saline solution. The animals were then anesthetized according to the University of
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Missouri Animal Care Regulations. Blood samples were collected after 30 min via
intracardiac puncture into the sterile polystyrene tubes containing heparin as an
anticoagulant. The animals were then sacrificed and liver, kidney, and brain samples
were obtained and kept on ice for immediate derivatization and analysis. The remaining
tissue samples were kept at -70oC for later analysis. The blood was centrifuged for 5 min
at 1000 x g to obtain plasma, which was immediately derivatized with NPM.

Preparation of solutions for calibration
Stock solutions of cysteamine were prepared by dissolving 1.2 mg of cysteamine
in 10 mL of serine borate buffer (SBB) to make a 1 mM solution of cysteamine, which
was further diluted with SBB to obtain 100 µM and 10 µM stock solutions. The stock
solutions were used to prepare standards for the calibration curve. Appropriate volumes
of cysteamine stock solutions were added to plasma and tissue samples in order to obtain
final concentrations of 50, 100, 200, 400, 600, 800, 1000, and 1200 nM for the calibration
standard. SBB was prepared by adding 15.74 g Tris-HCl, 0.618 g borate, 0.525 g serine,
and 0.393 g diethylenetriaminepentaacetic aced (DETAPAC) in 1 L of HPLC grade
water (pH = 7.0). NPM (1 mM) solution was prepared by dissolving 0.003 g of NPM in
10 mL acetonitrile. Antioxidant buffer was prepared by dissolving 1.2 g disodium
phosphate, 0.32 g sodiumdihydrogen phosphate, 100 µL butylated hydroxytoluene (BHT)
solution (0.1102 g BHT in 1 mL 100 % ethanol), 0.841 g aminotriazole, 0.039 g
DETAPAC, and 0.065 g sodium azide in 1 L HPLC-grade water.
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HPLC system
The HPLC system (Thermo Electron Corporation) consisted of a Finnigan ™
Spectra SYSTEM SCM1000 Vacuum Membrane Degasser, Finnigan ™ Spectra
SYSTEM P2000 Gradient Pump, Finnigan ™ Spectra SYSTEM AS3000 Autosampler,
and Finnigan ™ Spectra SYSTEM FL3000 Fluorescence Detector (λex = 330 nm and
λem = 376 nm). The HPLC column was a Reliasil ODS-1 C18 column (5 µm silica
packing material) with 250 x 4.6 mm (Column Engineering, Ontario, CA, USA). The
mobile phase was 70% acetonitrile and 30% HPLC water and was adjusted to a pH of
about 2 through the addition of 1 mL of both acetic acid and o-phosphoric acid. The
NPM derivatives were eluted from the column isocratically at a flow rate of 1 mL/min.
The chromatographic column temperature was ambient. There were very minor
fluctuations of retention times which could be neglected.

Assay procedures
Derivatization of cysteamine
The tissue samples from the livers, kidneys, and brains of adult Sprague Dawley
rats were homogenized (0.15 g/ml) in antioxidant buffer (prepared as described above
under solution preparation) to avoid oxidation. The plasma samples were diluted (1/5)
before derivatization. 10 μL of tissue homogenates or diluted plasma samples were mixed
with 240 μL of SBB and then derivatized at room temperature with 750 μL of NPM to
form fluorescent derivatives. Standard solutions of cysteamine were prepared by taking
appropriate volumes of stock solutions to obtain concentrations of 0, 50, 100, 200, 400,
600, 800, 1000, and 1200 nM in the tissue matrix. The resulting mixtures were
derivatized with 750 μL of 1.0 mM NPM solution in acetonitrile and left to stand for 5
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min at room temperature. At the end of the reaction time, 10 µL of 2 N HCl solution were
added to stop the reaction and stabilize the adducts. The final pH of the solution was
maintained at about 2 which is ideal for the stability of the NPM-cysteamine adducts. The
derivatized samples were filtered through a 0.45 µm acrodisc filter, and then injected into
the column in a reversed-phase HPLC system.

Protein assay
The protein contents of different tissue samples were determined by using the
Bradford method [16] in order to compare the concentration levels of CSH obtained
from the tissue samples. The homogenized samples were diluted to appropriate
concentrations prior to determination of protein levels. Concentrated coomasie blue (BioRad) was diluted 1:5(v/v) with distilled water; then 2.5 mL of the diluted dye were added
to 50 µL of the homogenized sample. The mixture was incubated at room temperature for
5 min, then the absorbance was measured at 595 nm by a spectrophotometer. The
concentrations of protein present in the homogenized samples were obtained by
comparing the absorbance values of the samples against the standard curve. The standard
curve was constructed using the bovine serum albumin (BSA), 0.25-1 mg/mL.

METHOD VALIDATION
Calibration curves
The calibration curves of CSH were plotted by using integrated peak areas as the
y-axis vs. standard CSH concentrations (0, 50, 100, 200, 400, 600, 800, 1000, and 1200
nM) as the x-axis. Linearity for the standards (without the tissue matrix) was obtained
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over a full range of 0-1200 nM with the calibration curve: y = 876.35x -5224.7 and a
correlation coefficient: r2 = 0.9993. Linearity for standards (with the tissue matrix) was
also obtained over a full range of 0-1200 nM, with the calibration curves in the plasma
and liver tissue matrix: y = 890.33x – 12871 and y = 856.62x – 14886 respectively. The
correlation coefficients were r2 = 0.9968 in the plasma matrix and r2 = 0.9965 in the liver
tissue matrix.

Accuracy, precision, and recovery
Six replicates of plasma and tissue samples were prepared, spiked with 50 nM,
100 nM, 600 nM, and 1000 nM of CSH, and then analyzed in order to determine
accuracy. The concentration points (50, 100, 600, and 1000 nM) were used as the true
values in the calculation of the deviations between the true values and the measured
values. The calculated deviations were then expressed as percentage to yield a relative
deviation (RD), which was used as a measure of accuracy. Within-run precision was
determined by analyzing six replicates of CSH-spiked control plasma and tissue samples,
at concentrations ranging from 50-1000 nM in one analytical run, and comparing the
CSH concentrations calculated from the peak areas of the six replicates in the matrix.
Between-run precision was determined by derivatizing six replicates of CSH-spiked
control plasma and tissue samples, at concentrations ranging from 50-1000 nM in three
different analytical runs, and comparing the CSH concentrations calculated from the peak
areas of the six replicates in each matrix. The coefficients of variation were calculated in
each matrix and used as a measure of precision. Relative recovery was determined by
spiking the brain, kidney, liver, and plasma samples with 50 nM, 100 nM, 600 nM, and
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1000 nM CSH in three replicates. The recoveries were calculated by comparing the
analytical results for the spiked samples with the unspiked pure standards at the four
mentioned concentrations that represented 100 % recovery. The coefficients of variation
(CV) for between-run and within-run precision, accuracy, and relative recovery of the
samples spiked with CSH (50, 100, 600, 1000 nM) in the tissue matrix and standards are
reported in Table 1. The coefficients of variation for within-run precision and betweenrun precision ranged from 0.68% to 9.90% and 0.63% to 4.17 %, respectively. The
within-run precision of 9.90% was obtained at 50 nM. The percentages of relative
recovery ranged from 94.1% to 98.6%.

Sensitivity and stability
The lower limit of quantitation (LLOQ) was the concentration of CSH when its
peak area was 10 times that of the peak area of the blank (signal-to-noise = 10). The
LLOQ of CSH was 50 nM (0.05 nmol/ml), and the detection limit was 10 nM (0.01
nmol/ml) (signal-to-noise = 3) with 5 µL injected sample volume. The autosampler
stability was measured by determining the six replicates of derivatized CSH spiked
plasma and tissue samples at three concentrations (100, 600, and 1000 nM). These were
kept in HPLC autosampler vials and stored at room temperature following 0, 6, 12, 24,
and 48 h of sample derivatization, or stored at 4oC for 1, 3, 7, and 14 days after sample
derivatization. The relative standard deviation was found to be less than 8 % when the
derivatized samples were stored at room temperature, and less than 15 % for samples
stored at 4oC.
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Investigating interference from other thiols
A standard mixture of 600 nM of cysteamine (CSH), N-acetyl-L-cysteine (NAC),
glutathione (GSH), cysteine (CYS), and homocysteine (HCYS), in a plasma matrix was
derivatized with NPM and analyzed by reversed-phase HPLC, as shown in the
chromatogram in Figure 2. All of the biological thiols mentioned above elute before CSH
and do not interfere with its detection.

RESULTS
In this investigation, CSH was derivatized with NPM and analyzed using the
reversed-phase HPLC with fluorescence detection method in isocratic mode. The tissue
samples (brain, kidney, liver) from treated adult Sprague Dawley rats were homogenized,
derivatized with NPM, and analyzed. The plasmas were also analyzed. Tissues of control
animals were spiked with varying concentrations of CSH and analyzed. Figure 1 shows
the derivatization reaction in which the thiols reacted with NPM to form fluorescent
adducts. Figure 2 shows the chromatogram of derivatized standard mixed thiols (600
nM): NAC, GSH, CYS, HCYS, and CSH in a plasma matrix. The biological thiols (CYS,
GSH, NAC, and HCYS) do not interfere with the detection of CSH since their peaks
come out before the CSH peak. Figure 3 is the chromatogram of a kidney sample
obtained from an animal administered 300 mg/kg body weight of CSH and sacrificed 30
min later. Figure 4 (a) shows the chromatogram of the control liver sample from a
Sprague Dawley rat given phosphate buffered saline solution only. There is no CSH peak
in this chromatogram. Figure 4 (b) shows the chromatogram of the liver sample obtained
from a rat that was administered 300 mg/kg body weight of CSH and sacrificed 30 min
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later. The CSH peak was observed at 17 min. The concentrations of CSH obtained in the
plasma and tissues are reported in Table 2. The levels of other important biological thiols
(such as GSH and CYS) in the tissue samples and plasma were calculated using the thiol
concentrations (nM) of homogenized tissue solutions, divided by the protein content in
the tissue and expressed as nmol/mg protein. This data is reported in Table 2. The
hydrolysis peak is the peak of NPM-water adduct, which results from the reaction of
excess NPM with water.

DISCUSSION
In spite of the attempts that have been made to analyze cysteamine in biological
samples, to the best of our knowledge, no detailed study has been reported in the recent
past on determination of cysteamine in biological samples. Ricci et al. (1983) published
an analytical method for determining cysteamine in biological samples but the
derivatization procedure used is complex, involving coupled enzyme reactions along with
detailed pre-treatment of the samples. Furthermore, no clear detection method has been
shown. Stachowicz et al. (1998) have reported determination of cysteamine in human
serum. However, their work did not include the determination of cysteamine in other
tissue samples such as the brain, kidney, and liver. Moreover, the derivatizing agent they
used was mono bromobimane (mBBr) as a fluorescent probe, which can measure many
biologically important thiols since it is both specific and sensitive to thiols. However, the
sample preparation and derivatization are complex and time consuming, and involve the
incubation of samples in the dark. In our study, we used N-(1-pyrenyl) maleimide (NPM)
as the derivatizing agent [17]. NPM is very specific for thiols. The derivatization
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procedure using NPM is very simple (not requiring any special conditions), and the
reactions take place at room temperature under ordinary laboratory conditions. NPM has
the added advantage of increased sensitivity and rapid analysis, compared to the mBBr
method. Although NPM has hydrolysis peaks, these come up well before the cysteamine
peak; no interference has been observed.
The methods of detection reported in the literature, such as high performance
liquid chromatography with ultraviolet detection [18], ion exchange column
chromatography, and capillary electrophoresis [19, 20, 21], are well documented as
lacking sensitivity [22]. Therefore, we focused on the use of reversed-phase HPLC with
fluorescence detection for determining cysteamine in biological samples. This is a very
sensitive method with high reproducibility and precision. The LLOQ of CSH in
biological samples by our method was 0.05 nmol/ml, and the detection limit was 0.01
nmol/ml (signal-to-noise = 3), which is better than the LLOQ of 0.1 nmol/ml of plasma
reported by Kusmierek et al. using HPLC with ultraviolet detection after precolumn
derivatization, and the LOD of 0.061 µmol/L reported by Lochman et al using highthroughput capillary electrophoretic method for determination of total aminothiols in
plasma and urine [18, 9]. A plasma cysteamine concentration of 5µM in humans 8 hours
after an oral dose of 1200 mg is reported by Stachowicz et al [8]. It is important to note
that cysteamine easily undergoes oxidation at room temperature to form mixed disulfides,
therefore, cysteamine should be dissolved in serine borate buffer, in which it remains
stable for 7 days at 4oC. In this study, we have demonstrated that HPLC with
fluorescence detection, using NPM as the derivatizing agent, is a very suitable method for
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analyzing and detecting cysteamine in biological samples. The method is rapid, simple,
and sensitive, and could be used in health institutions for pharmacokinetic studies.
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Figure 2. Chromatogram of derivatized standard mixed thiols (600 nM): NAC, GSH,
CYS, HCYS, and CSH in a plasma matrix. Separation conditions: an ODS-1 C18 Column
(5 µm packing material) with 250 x 4.6 mm (i.d) was used for the separation. The NPM
derivatives were measured by a fluorescence detector (λex = 330 nm and λem = 376 nm).
Flow rate was 1ml/min. The mobile phase was 70% acetonitrile and 30% HPLC water
and was adjusted to a pH of about 2 through the addition of 1 mL of both acetic acid and
o-phosphoric acid in 1 liter of mobile phase.
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Figure 3. Chromatogram of a kidney sample obtained from an animal sacrificed 30 min
after the administration of 300 mg/kg body weight of CSH. The concentrations of GSH,
CYS, and CSH were 3.3 ± 1.2, 34.5 ± 6.3, and 24.5 ± 1.2 nmol/mg protein respectively.
The separation conditions are the same as mentioned under Figure 2.
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(b)
Figure 4. (a) Chromatogram of a control liver sample obtained from an animal
administered phosphate buffered saline solution only. (b) Chromatogram of a liver
sample obtained from an animal sacrificed 30 min after the administration of 300 mg/kg
body weight of CSH. The separation conditions are the same as mentioned under Figure
2.

115
Table 1. Between-run and within-run precisions, accuracy, and relative recovery of
replicate samples spiked with CSH (50, 100, 600, and 1000 nM) in plasma and tissue
sample matrices, and standards.

Sample matrix

Brain

Kidney

Liver

Plasma

0.73-

0.63-

1.42-

1.15-

3.19%

1.83%

3.32%

4.17%

1.82-

1.55-

0.78-

2.91-

9.20%

4.04%

5.82%

4.49%

Accuracy

0.03-

3.05-

4.90-

3.95-

(n=6)

6.90%

5.01%

4.98%

5.88%

94.1 ±

94.9 ±

94.7 ±

98.6 ±

7.0%

6.9%

2.8%

5.0%

Between-run
precision
(n=6)
Within-run
precision
(n=6)

Relative
recovery
( n=3)

Standard

1.38-1.99%

0.68-9.90%

1.50-3.60%

N/A

(Percentage relative recovery is reported as the average relative recovery ±
standard deviation. N/A= not applicable)
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Table 2. Thiol levels in biological samples 30 min after oral administration of 300 mg/kg
body weight.

Samples (n=3)
Brain

Kidney

Liver

Plasma

Control
CSH-treated
Control
CSH-treated
Control
CSH-treated
Control
CSH-treated

CSH

GSH

CYS

ND

13.6 ± 1.1

1.6 ± 0.3

21.8 ± 1.7

15.8 ± 2.4

1.9 ± 0.5

ND

2.1 ± 0.5

28.2 ± 3.1

24.5 ± 1.2

3.3 ± 1.2

34.5 ± 6.3

ND

19.2 ± 3.7

3.4 ± 0.2

9.5 ± 1.6

21.3 ± 4.2

2.7± 0.4

ND

6.2 ± 1.1

15.6 ± 1.8

22.4 ± 2.8

7.3 ± 1.4

18.4 ± 2.9

Plasma sample units were in µM, units for tissue samples are in nmol/mg protein. The
values are mean ± standard deviation. ND: not detectable.
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